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Abstract
Though Parkinson’s Disease is known to be caused by cell death in one region of the
brain, and though the protein ↵-synuclein is known to be associated with it, the causes
are still poorly understood. It has not yet been shown how ↵-synuclein may cause cells
to die, with research focusing on the range of structures the protein is able to adopt. The
classic amyloid fibrils are currently believed to be non-toxic, but smaller, soluble oligomers
appear to be the toxic species. Key to toxicity and to the normal function of ↵-synucein
(also unknown to-date) appear to be the ability of the protein to bind to lipids, as toxicity
may be due to oligomers forming pores in cells, and the normal function of the protein
may be in vesicle transport.
The work presented in this thesis represents a collection of studies, across several disciplines,
that test aspects of the behaviour of ↵-synuclein. Circular dichroism and fluorescence data
presented here show that the protein interacts with the lipid POPS in a concentration-
dependent manner. Linear dichroism was an important and complementary technique to
these, but required some method refinement and sample preparation improvement. This
work is presented in this thesis, alongside experimental and theoretical studies into the
behaviour of lipid vesicles in Couette flow. It was shown that certain lipids perform better
in Couette flow, particularly the mixture of POPC and POPS. This informed the linear
dichroism studies, and enabled experiments suggesting that oligomers of ↵-synuclein may
insert across the membrane of vesicles. If confirmed, this would support the amyloid pore
theory of ↵-synuclein toxicity.
xvii
Chapter 1
Introduction
Amyloid proteins are thought to be responsible for several neurodegenerative diseases,
yet the mechanisms by which these diseases are caused are poorly understood. In this
thesis, work is presented that aims to understand the mechanism of one such protein,
↵-synuclein, by applying spectroscopic techniques in several experimental configurations.
It was also apparent that one of the key techniques, linear dichroism, was not optimised
for the experiments carried out here. Work is presented on improving the usability of the
technique, and the quality of data generated in this way.
1.1 Amyloid proteins and disease
In neurodegenerative amyloid diseases, three proteins are considered especially important:
↵-synuclein (↵S), amyloid-  (A ), and prion protein (PrP). These proteins, however,
are found in both healthy and diseased individuals, making understanding their biology
both interesting and extremely important. Neurodegeneration is caused by the death of
neurones in various regions of the brain, so a major therapeutic target is the prevention
of cell death. Therefore, much research is aimed at understanding the cause of cell death;
a process still not fully understood.
Prusiner was able to show in the early 1980s that prions could be linked to scrapie (a
sheep form of prion disease), and this knowledge soon led to the understanding that other
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diseases (e.g. bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob
Disease (vCJD)) were also due to prion toxicity (Prusiner, 1982). Amyloid-  was known to
be a major component in so-called amyloid plaques in Alzheimer’s Disease (AD) patients,
as was the insolubility of these protein aggregates (Selkoe et al., 1982), leading to the
hypothesis that disease was cause by amyloid protein fibrils. Since fibrils of ↵-synuclein
were found in the Lewy Bodies of Parkinson’s Disease (PD) patients, this theory seemed
to solve the question of why neurodegeneration occurred.
Recently, however, the focus of the field has been shifted away from the large insoluble
aggregates of amyloid proteins to smaller, soluble oligomers. These species are now
believed to be more able to exert toxic e↵ects on neurones, and may be the true causative
agent of disease (Selkoe, 2008; Simoneau et al., 2007). Oligomerisation was known to occur,
and to be di↵erently regulated for di↵erent mutants of the proteins, but was previously
thought to be simply an intermediate step to fibril formation (fibrillogenesis) (Lotharius
& Brundin, 2002).
It has been possible in the last decade to hypothesise on what caused cell death, even before
oligomers were known to be the likely culprit. Oxidative stress is a damage mechanism
suggested for a number of degenerative processes, ageing and neurodegeneration being
among them. In PD, Lotharius and Brundin discussed a model of cell death by oxidative
stress. Cellular metabolism of dopamine generates reactive oxygen species (ROS) such as
superoxide anions (O · –2 ), dopamine-quinone species (SQ
·), and hydroxyl radicals (OH ·).
The authors suggest that when the dopaminergic neurones are damaged by a trigger of
oxidative stress, an excess of dopamine is able to enter their cytoplasm. Cytoplasmic
dopamine would then be metabolised to ROS, which causes further damage to the cell,
eventually forcing it onto the apoptosis pathway. The region of the brain in which
most dopinanergic neurones are found is the substantia nigra, the region that su↵ers
degeneration in PD. If one accepts that ↵-synuclein has a role in transporting vesicles
containing dopamine (unproven but often suggested), one can easily deduce how damage
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to the protein would lead to disruption to the dopamine supply, and whatever further
damage that would cause (Bellucci et al., 2012). Figure 1.1 presents a schematic of this
pathway to damage. Since the Lotharius and Brundin review, other evidence has come to
light implicating ↵-synuclein in other forms of damage: malfunction of homeostasis, nitric
damage, and neuroinflammation to name a few (Lotharius & Brundin, 2002; Jellinger,
2012).
Figure 1.1: Image reproduced from Bellucci et al., 2012 showing how ↵-synuclein may disrupt
the pathways associated with dopamine (DA), and therefore lead to damage in the cell.
Whether it is oligomer, or fibril, or some as yet unknown form of the protein that causes
disease, it is clear that the native proteins are not harmful, but in fact may be important
in various pathways, such as the putative role of PrP in neuroprotection against several
insults (Roucou et al., 2004). As with many diseases, a genetic link was sought. The
symptoms of Parkinson’s Disease can be caused by environmental factors (e.g. the toxin
MPTP, now used in animal models of PD), but a small number of cases have a genetic link.
Knockout mice have been bred that lack the gene for ↵-synuclein, but they do not show PD
symptoms (Kurz et al., 2010). Instead, only curious neurochemical changes were observed.
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These include e↵ects such as fewer synaptic vesicles in knockout mice, especially in the
so-called reserve pool of vesicles recruited during high-frequency stimulation. Recent work
using mice deficient in ↵-synuclein showed that glyoxylase I expression was up-regulated,
and the animals exhibited glycation stress. These data suggest that ↵-synuclein may be a
key regulator of glucose metabolism in the brain, and may have a role in vesicle transport
to or from the reserve pool (Lotharius & Brundin, 2002; Kurz et al., 2010).
Five mutations in ↵-synuclein have been found to cause PD symptoms: Ala30Pro, Ala53Thr,
Glu46Lys, His50Gln and Gly51Asp (A30P, A53T, E46K, H50Q, and G51D) (Conway et al.,
1998; Warner & Schapira, 2003; Zhu et al., 2003; Choi et al., 2004; Zarranz et al., 2004;
Appel-Cresswell et al., 2013; Fares et al., 2014). With this information, transgenic mice
have been developed, and with these lines researchers have had further success in producing
PD-like symptoms. Lines that overexpress A53T mutant ↵-synuclein have been variously
shown to lose motor neurones and develop Lewy Body-like inclusions, though these traits
are not universal amongst the mouse lines (Lotharius & Brundin, 2002). A30P, A53T, and
E46K constructs, when expressed in mice or in vitro, have been shown to form fibrillar
structures, such as those found in Lewy Bodies of PD patients. Figure 1.2, reproduced
from Choi et al., demonstrates morphological di↵erences in fibrils formed by the di↵erent
↵-synuclein mutants, shown by taking electron microscopy (EM) images of the protein
after incubation.
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Figure 1.2: Electron micrographs of the filaments formed by forms of alpha-synuclein. (A) -
wild type, (B) - A30P, (C) - E46K, (D) - A53T (Choi et al., 2004).
At the time of publication of the Choi et al. study, E46K was a recently found ↵-synuclein
mutant, and its properties were not yet understood. The authors here chose to probe
some characteristics of E46K, in the hope of revealing some routes to pathogenesis (Choi
et al., 2004). One key study determined that fibrillation of WT ↵-synuclein was much less
e cient than for all three mutant forms. E46K and A53T share almost identical kinetics
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(measured by Thioflavin T (ThT) fluorescence).
It has been shown that amyloid-  and prion protein both cause disease. A  has been
linked with Alzheimer’s Disease since the 1980s, and oxidative stress is believed to be the
method by which cells are killed (Varadarajan et al., 2000). It has been known for many
years (reviewed in 1994 by D. Selkoe) that di↵erent forms of Alzheimer’s Disease could
be caused by genetic alterations in several aspects of the relevant cellular biochemistry:
the tra cking of amyloid precursor protein (APP), the processing enzymes that interact
with APP, heterogeneity (or otherwise) of A  peptides, proteolytic systems that could
degrade A , kinetics of fibrillogenesis, and the other proteins that can interact with A 
aggregates. All of these associated proteins can lead to Alzheimer’s Disease if mutated in
some way (Selkoe, 1994).
PrP is believed to exert its toxic e↵ect through aggregation at the cellular membrane.
If enough of the protein accumulates, biochemical pathways are interrupted or altered
(e.g. proteosomal or other degradation pathways), thereby triggering apoptosis (Simoneau
et al., 2007). Wild type PrP, known as PrPC , does not cause disease. Its function is
not yet understood, but may be neuroprotective to oxidative stress or apoptotic signals
(Solomon et al., 2010). This would then imply that when the protein is damaged by
mutation, leading to its aggregation and failure of function, cells subjected to previously
non-e↵ective apoptotic signals would die.
The studies discussed above make clear the importance of the interaction of amyloid
proteins in general with membranes. In the next section, this general amyloid-lipid
interaction is probed more specifically, to determine the relevance of work on ↵-synuclein
and lipids.
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1.2 Protein-Membrane interaction and toxicity
A comparison was also made between how well the di↵erent ↵-synuclein mutants bound
two di↵erent types of liposome. Lipids used were brain PC and brain PS (phosphocholine
and phosphoserine), i.e. with a mixture of head groups and charges. The liposome
proportions were PC:PS:cholesterol 52.5:17.5:30 mol% and 35:35:30 mol%, with the former
being more similar to synaptic vesicle construction. The liposomes were fluorescence
labelled with 3,30-dioctadecyloxocarbocyanine perchlorate (DiO). The E46K mutant had
88% stronger binding to the first liposome type than wild type (WT) ↵-synuclein. It also
bound the second liposome type 56% more strongly. Other disease-associated forms of
↵-synuclein have di↵erent e↵ects: A53T mutation does not significantly alter liposome
binding, whereas A30P reduces the ability of the protein to bind liposome. This supports
the hypotheses set out by Auluck, Caraveo and Lindquist into the modes of toxicity of
mutant ↵-synuclein. These authors suggested that E46K and A53T ↵-synuclein caused
disease by not releasing reserve pool vesicles to the synapse, whereas A30P would cause
disease by releasing too much too quickly (e↵ectively the same as having no ↵-synuclein
present) (Auluck et al., 2010; Choi et al., 2004).
Mice expressing the A53T mutant show marked degeneration of motor neurones, and
other data suggest that normal ↵-synuclein function might be in neuronal or synaptic
maintenance. The protein has been shown to associate with the synaptic region of
neurones, with up to 50% being bound either to the cell membrane, or to vesicles. Mutated
forms of the protein have less ability to bind membranes: A30P has no capacity to form
these interactions, possibly due to a kinked structure, and A53T loses some of its ability
to bind planar lipid membrane, though it may still bind vesicles (Lotharius & Brundin,
2002).
Measurements of how e↵ective oligomeric ↵-synuclein could be at membrane disruption
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have been made by Sto¨ckl, Claessens and Subramaniam (Sto¨ckl et al., 2012a). The authors
discuss the two leading models for how this would occur: either oligomers forming pores
through the membrane allowing molecules to pass, or by simply disrupting the membrane
structure enough to cause problems for the integrity of the cell. By using a kinetic
measurement approach, the authors hoped to gain an insight into which of these is more
likely to be the case. The kinetics of permeabilisation would appear di↵erent for the
di↵erent e↵ects of destabilising the membrane or punching a hole through it.
Vesicles containing C6-NBD-PC (a fluorescent lipid) were exposed to a solution of 10mM
dithionite – a species that bleaches C6-NBD-PC. This was performed at a range of
concentrations of ↵-synuclein. By measuring the change in fluorescence, it was possible
to deduce how much dithionite was passing through the vesicle membrane, and therefore
how permeable the vesicle was. In all cases, the fluorescence dropped quickly after the
addition of dithionite, but only to around 50% of maximum in the 0 ↵-synuclein control
experiment. It was shown that fluorescence decreased further for every higher ↵-synuclein
concentration; with 1µM ↵-synuclein the amount of C6-NBD-PC remaining unbleached
decreased to below 20%, thereby showing that ↵-synuclein increased membrane permeability
according to its concentration (Sto¨ckl et al., 2012a).
Membranes containing the lipids POPG and POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-(10-rac-glycerol), and 1-palmitoyl-2-oleoyl -sn-glycero-3-phosphocholine) at various
ratios were prepared. POPG is negatively charged, and is therefore the lipid to which ↵-
synuclein will bind. Again, the vesicles contained C6-NBD-PC, and were exposed to
dithionite. A di↵erence in fluorescence for di↵erent amounts of POPG would show that
lipid composition influences the ability of ↵-synuclein to permeabilise the membrane. It
was shown that over 90% of the vesicle membrane had to be composed of POPG for
↵-synuclein to a↵ect the rate at which permeabilisation occurred. Therefore, the protein
is only able to disrupt membranes substantially if the lipids in the membrane are mainly
negatively charged. Due to the calculated rate constants by which dithionite influx occurs,
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and the rate at which other phenomena such as flip-flop occur, where flip-flop is defined
as lipid molecules swapping to the other leaflet of the membrane, the authors conclude
that permeabilisation is by membrane destabilisation, rather than pore formation (Sto¨ckl
et al., 2012a; D M Michaelson, 1983).
Auluck, Caraveo and Lindquist presented a review of the theories behind the toxicity of
↵-synuclein. They discuss the strong association, shown in many model systems, between
↵-synuclein and membranes in vivo and in vitro. It was shown in yeast models that both
the wild type and A53T forms of the protein localise to the cell membrane. At higher levels
of expression, both forms of the protein accumulated in so-called foci in the cytoplasm,
shown by EM to be vesicles decorated with the protein (Auluck et al., 2010; Outeiro &
Lindquist, 2003; Gitler et al., 2009). This reinforces the view discussed by Lotharius and
Brundin that ↵-synuclein has a role in vesicle maintenance and recycling (Lotharius &
Brundin, 2002), so that defects in the protein result in defects in this system. In yeast,
high levels of ↵-synuclein have been shown to a↵ect the endoplasmic reticulum (ER)–Golgi
vesicle transport system: vesicles are formed at the ER correctly, but on reaching the Golgi
they do not fuse in the expected manner (Gitler et al., 2008).
It has also been shown that dopaminergic neurones in Caenorhabditis elegans made to
express ↵-synuclein will be lost within 72 hours. Genes for endocytosis and protein
degradation are up-regulated in these animals, and if endocytotic genes are down-regulated
instead ↵-synuclein has increased toxicity (Lasko et al., 2003). Overexpression of human ↵-
synuclein inDrosophila has resulted in the observation of cytoplasmic inclusions, reminiscent
of Lewy Bodies and Neurites, and further experiments have shown that lipid metabolism
is damaged in these insects (Feany & Bender, 2000; Scherzer et al., 2003).
Auluck et al. describe their model for how ↵-synuclein exerts its toxicity. They propose
that under normal conditions, ↵-synuclein exists as an unfolded cytoplasmic protein.
When the protein comes into contact with lipid membrane, the structure changes to
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give rise to ↵-helical domains at the lipid surface. Mutant ↵-synuclein, on the other
hand, exhibits di↵erent behaviour. On lipid membrane, or in the cytoplasm, it is able to
dimerise, forming  -sheet structures. These dimers may further oligomerise, forming toxic
species as they do so, spreading throughout the cell damaging membrane around many
organelles (Auluck et al., 2010). These processes are depicted in Figure 1.3.
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Figure 1.3: (Top) Normal cytoplasmic alpha-synuclein, (middle) alpha-synuclein associating
with membrane, (bottom) mutant alpha-synuclein associating with membrane in an incorrect
manner, then oligomerising. Reproduced from Auluck et al., 2010 (Auluck et al., 2010)
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Intriguingly, the five sites of PD-causing mutation mentioned so far (A30, E46, H50, A53,
G51) are within a very compact region, Four are spatially close, with three on the same side
of one of the ↵-helices formed on lipid binding. This is illustrated in Figure 1.4 (Pettersen
et al., 2004; Ulmer et al., 2005). This may suggest that the nature of helix formed on lipid
binding is influential in whether disease occurs, but this is yet to be proven.
Figure 1.4: Micelle-bound ↵-synuclein, with polypeptide chain in blue, and residues 30, 46, 50,
51, and 53 in red. Note the proximity of E46, H50, G51, and A53, as well as the similarity in
orientation around the ↵-helix. Initial and final residues of helices are coloured purple, and labelled
with their sequence number. Image prepared using Chimera, coordinate file downloaded from the
protein database, PDB ID: 1XQ8.
Auluck et al. discuss the di↵erent ↵-synuclein mutants and their likely e↵ect on synapse
behaviour. During spells of repeated stimulation, additional vesicles must be recruited
from a so-called reserve pool (Lotharius & Brundin, 2002). The wild type protein maintains
the reserve pool of synaptic vesicles by forming interactions between small numbers of the
structures. Mutants A53T and E46K alter the vesicles on binding, since they have a
di↵erent binding a nity to WT ↵-synuclein, and lead to far too many vesicles being kept
in the reserve pool, reducing synaptic transmission. A30P mutant ↵-synuclein reflects
the consequence of lacking ↵-synuclein altogether, with the protein unable to bind to the
vesicles e ciently. This leads to depletion of the reserve pool as vesicles are released too
frequently (Auluck et al., 2010).
It is the conclusion of the Auluck et al. review that toxicity comes as a result of dimerisation
of mutant protein at the synapse. Dimers form soluble oligomers which may then disperse
into the rest of the cell, damaging the organelles they come into contact with, particularly
12
CHAPTER 1. INTRODUCTION
the endoplasmic reticulum and mitochondria, possibly by oxidative stress mechanisms.
The key pathogenic e↵ect would be at the synapse, where vesicles would inappropriately
release their contents, and neurones would be stimulated incorrectly. When dopaminergic
neurones are a↵ected, motor defects would result. These conclusions echo the earlier
conclusions of Lotharius and Brundin (Lotharius & Brundin, 2002; Auluck et al., 2010).
Two recent reviews have collected the information on how ↵-synuclein structure relates to
membrane interaction. Dikiy and Eliezer focussed on the structural information gathered
for the protein in its bound states. It is known that under various conditions, ↵-synuclein
may fold into an extended-helix structure, or into a broken-helix (Bussell & Eliezer, 2004;
Bussell et al., 2005; Georgieva et al., 2008). The authors postulate that the broken-helix
conformation is only adopted when the vesicle upon which the protein is bound, approaches
the synaptic membrane (Dikiy & Eliezer, 2012). Their summary of the current models is
presented in Figure 1.5.
Figure 1.5: Summary of various membrane interaction models, reproduced from Dikiy and
Eliezer, 2012 (Dikiy & Eliezer, 2012). Note the changes from randomly structured free protein, to
extended-helix, to broken-helix.
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The findings of Dikiy and Eliezer are repeated, and elaborated upon by Pfe↵erkorn, Jiang,
and Lee (2012). In their review, the authors discuss the wide range of techniques used to
probe ↵-synuclein behaviour at membranes. A focus of the review is that the dimensions
of the lipid structure, to which the protein is binding, may have substantial impact on the
structure of ↵-synuclein. NMR structures for micelle-bound ↵-synuclein show clearly the
broken-helix, but, when larger vesicles are used, the extended-helix is observed. There is
also an e↵ect on how easily ↵-synuclein binds lipids: the protein appears to bind more
readily to smaller vesicles, perhaps due to packing defects. Finally, the authors examined
evidence describing the interaction of disease-related mutants with lipid structures. A53T
does not appear to alter lipid binding, A30P appears to reduce lipid-binding, and E46K
appears to enhance lipid-binding (Pfe↵erkorn et al., 2012).
It is important to address the question of how ↵-synuclein binds membrane, because this
may lead to either an understanding of the method of toxicity, or to potential treatment
targets for PD, and many laboratories have contributed to the literature addressing this
question (Zhu et al., 2003; Lee et al., 2004; Lashuel et al., 2007; Ferreon et al., 2009; Burke
et al., 2013; Khalaf et al., 2014). Using circular dichroism (CD) and other techniques,
Martinez et al. investigated the interaction of ↵-synuclein and gangliosides to determine
which of these lipids would bond with the protein, and what the e↵ects were of such
an interaction (Martinez et al., 2007). It was shown that ↵-synuclein has specificity for
GM1 (Monosialotetrahexosylganglioside) over other forms of lipid. Measured by circular
dichroism, the ↵-helical proportion of the protein was shown to change when exposed
to di↵erent lipid mixtures. The protein on its own, or with DPPC (1,2-dipalmitoyl-sn-
glycero-3-phosphocholine) and cerebrosides, or with ceramides, gave CD spectra as for an
unfolded protein. When exposed to total brain gangliosides, the CD spectra displayed
some signs of ↵-helix structure, but not significantly. When exposed to vesicles containing
only GM1, the CD spectra showed the characteristics of that for ↵-helically folded protein,
showing significant interaction with this lipid, and much greater interaction than that for
14
CHAPTER 1. INTRODUCTION
with other lipids.
Specificity for GM1 has been observed in A  (Yanagisawa et al., 1995; Matsuzaki et al.,
2010), and the influence of GM1 and lipid rafts on prion aggregation and toxicity has
also been seen (Fantini et al., 2002; Sanghera et al., 2011). GM1, therefore, is likely to
be involved at a key step in all amyloid diseases: the step in which the protein binds
membrane. It is also likely to be essential to the normal function of the protein, with
some structural change needed to make this interaction pathogenic.
Martinez et al. were able to show that GM1 influenced the formation of ↵-synuclein
oligomers. Atomic Force Microscopy was used to analyse ↵-synuclein structures following
incubation in di↵erent conditions. The authors examined samples incubated with and
without vesicles containing GM1. In the sample exposed to GM1, oligomers of ↵-synuclein
were observed that were not seen in samples incubated without vesicles. Bands corresponding
to oligomers were also seen by native polyacrylamide gel electrophoresis (PAGE) at two
di↵erent sizes. No oligomers were observed in samples exposed to di↵erent lipids, or even
total brain gangliosides (Martinez et al., 2007).
Interestingly, it was shown that fibrils were likely to form when Martinez et al. exposed
the protein to total brain lipid, but not when it was exposed only to GM1. Exposure
of ↵-synuclein to vesicles of total brain lipid extract – containing approximately 10%
phosphotidylserine (PS) – lead to accelerated fibril formation. This accelerated fibrillation
is counteracted by a higher GM1 content in the vesicles to which ↵-synuclein is exposed.
Vesicles containing 20% GM1 removed the acceleration e↵ect completely, and by 50%
GM1 fibrillation was eliminated. This was confirmed by ThT fluorescence and TEM
(Martinez et al., 2007).
CD showed no significant formation of secondary structure in the 20% GM1 vesicle
samples, but in the 50% GM1 samples ↵-helical structure was shown. These results
confirmed previous findings that ↵-helical ↵-synuclein inhibits or eliminates its fibrillation
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(Zhu et al., 2003). After incubation,  -structure was seen by circular dichroism, suggesting
that these non-fibrillar oligomers possess significant  -sheet regions. Martinez et al.
conclude that, since they have shown interaction between the two species, ↵-synuclein
would localise to regions of the membrane enriched with GM1 – so-called rafts or caveolae
– which are present at synapses. In these regions there is sometimes as much as 50%
GM1, due to ganglioside self-association, thereby presenting a large area of lipid that may
interact with ↵-synuclein. Here, with wild type ↵-synuclein, fibrillation would have an
extremely low chance of occurring. This interaction, they deduce, must be essential to
the function of the protein, and therefore requires detailed further study (Martinez et al.,
2007).
Given that it has been shown that ↵-synuclein interacts with the gangliosides GM1 and
GM3 (Martinez et al., 2007; Di Pasquale et al., 2010), Fantini and Yahi decided to use a
theoretical approach to investigate how this is accomplished, and the consequences of this
interaction (Fantini & Yahi, 2010, 2011). The authors compared the primary structures of
the glycosphingolipid–binding motif (GBM) of ↵-synuclein to that of Helicobacter pylori
adhesin, HIV-1 gp120 v3 loop, GM1–binding peptide, human Prion Protein (PrP), and
human amyloid- . This analysis revealed that the domains share a common sequence,
written as: (K/H/R)-X1 4-(Y/F)-X4 5-(K/H/R). At least one of X1 4 must be G and
X4 5 are usually G or T. They make further interesting points with regard to the central
aromatic residue: Y39 for ↵-synuclein and Y10 for A . This amino acid is found in the
same location both in the fragment analysed for alignment comparison, and in the whole
protein. It is flanked by basic residues in both ↵-synuclein and A . Through molecular
dynamics simulations, several mutants of ↵-synuclein were examined for interaction with
GM3. It was found that Y39A had much lower a nity for GM3, showing that this
interaction depends heavily on the amino acid at position 39. Y39F, a mutant replacing
the tyrosine with phenylalanine (another aromatic residue), was able to interact almost as
strongly as the wild type protein. Therefore, the aromatic group at this point is presumed
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to be essential to lipid binding of ↵-synuclein. The Fantini and Yahi model for binding of
↵-synuclein to gangliosides is shown in Figure 1.6.
Figure 1.6: Figure reproduced from Fantini and Yahi, 2011, showing the interactions of ↵-
synuclein with gangliosides, around residue Y39. Of particular relevance is panel (d), in which
Y39 is coordinated by interactions of K34 and K45 with the sugar moieties of GM1.
It has been discussed in this Section that both lipid choice and protein have impact on the
interaction between protein and membrane. In the next Section more detail on membrane
composition is presented, and the vesicles used in work presented later in this thesis are
introduced.
1.3 Model membranes for lipid-binding studies
E↵orts by some researchers to employ lipid vesicles in their studies have been discussed
above. For the studies presented in this thesis, it was necessary to choose a set of suitable
and interesting lipids that may have roles in the interaction between ↵-synuclein and
membranes. A single lipid species alone does not provide an accurate representation
of neuronal membrane. Cotman et al. and Breckenridge et al. examined neuronal
membranes in 1969 and 1972, respectively (Cotman et al., 1969; Breckenridge et al., 1972).
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In the former study, it was found that phospholipids PC and phosphoethanolamine (PE)
constituted ⇠60% of total membrane lipid, with cholesterol and ceramides making up
⇠ 20%. PI (phosphoinositol) and PS also make up around 10%, as do glycolipids in
total brain lipid. However, glycolipids were found to be a smaller component at synapses,
making up only 1% of lipid there.
Breckenridge et al. realised that the Cotman study had not investigated the proportion
of lipid that was ganglioside; a matter of concern because in fact gangliosides are a major
component of neuronal membrane. This study found that ganglioside is approximately
13%, with phospholipids PC, PE, PS, and PI making up ⇠ 71% altogether. Cholesterol,
they found, is only 15% of total lipid. Discrepancies can be accounted for by the missing
ganglioside fraction from the Cotman study.
Potentially key lipid head groups for the present work are, therefore, PC, PA (phosphate),
PG (phosphoglycerol), PE, PS, PI, cholesterol, and GM1. These represent measurable
components of real neuronal membranes, i.e. the lipids that ↵-synuclein would typically
encounter. Zhu, Li and Fink carried out early work to determine how strongly ↵-synuclein
interacts with di↵erent lipids (Zhu et al., 2003). They found that binding a nity is greatest
for PA, with PG, PS, and PE being slightly lower. These lipids have charged head groups,
thereby suggesting a means of interaction with ↵-synuclein. Another key decision in
selecting lipids for this study was the length of the acyl chains in the molecules. Since
pure lipids were to be used, it was impossible to replicate the complexity of true neuronal
membranes. Yu et al. determined the composition of a brain lipid extract by NMR, and
found that lipids with longer acyl chains accounted for larger proportions of the total
mixture than those with smaller chains (Yu et al., 2006).
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It was decided that for the primary ↵-synuclein–lipid binding studies the optimal balance
of natural occurrence and ability to work with the lipid was to use lipids with acyl chains
of lengths 18 and 16 carbon atoms. The chains were also minimally unsaturated, with
only one double bond per molecule, introducing some fluidity without compromising the
structural integrity. These are known as PO lipids, where PO is defined as 1-palmitoyl-
2-oleoyl-sn-glycero-3-R, and R is defined as the lipid head group. The structure of these
lipids is shown in Figure 1.7.
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Figure 1.7: Commonly used phospholipids, some referred to in this thesis, and in references.
From top: POPA, POPE, POPC, POPS, POPI.
19
CHAPTER 1. INTRODUCTION
Also used in the present work is cholesterol. This molecule has a key role in stabilising
cellular membranes, and can be responsible for fluidity and rigidity properties of lipid
structures. It is necessary to use cholesterol here to more accurately simulate real cell
membranes, and reflect conditions ↵-synuclein would encounter in cells. Cholesterol is
shown in Figure 1.8 (Ohvo-Rekila¨ et al., 2002).
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Figure 1.8: Cholesterol
The sphingolipid sphingomyelin (SM1) was incorporated into vesicles for some of the
studies in this work. Its structure is shown in Figure 1.9. SM1 has been implicated in
signalling pathways, and apoptotic pathways, and it has many putative roles in binding
events. Since it it prevalent in neurones, SM1 was judged to be a good candidate for
amyloid binding (Zhang et al., 1997).
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Figure 1.9: Sphingomyelin
Finally, the ganglioside GM1 was incorporated into our model membranes. GM1 is an
important lipid for many binding processes, including binding the cholera toxin, and is
found in large quantities in neuronal membranes. GM1 is found in vivo partitioned into
lipid rafts, which have been reconstituted in vitro (Dietrich et al., 2001a,b; Mocchetti,
2005). It seems likely that these would be areas of major a nity for ↵-synuclein. GM1
is shown in Figure 1.10. It is the plentiful charged groups and side chains that make the
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molecule able to bind the protein.
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Figure 1.10: GM1
The lipids discussed above, particularly SM1 and cholesterol, have often been implicated
in the formation of lipid raft domains, where narrower lipid molecules are able to pack
together more closely and present an concentrated region of head groups to the bulk
solution. Figure 1.11 shows how this kind of domain may exist as part of the lipid
bilayer. These domains have often been suggested as binding targets for amyloid proteins,
though other researchers dispute their existence (Dietrich et al., 2001b; Fantini et al., 2002;
Pinheiro, 2006; Lingwood & Simons, 2010). Whether they are permanent, transient, or
merely hypothetical, these domains incorporate lipids that may influence the binding of
↵-synuclein to membranes, and therefore are rightly considered here.
Lipid raft 
G S
C
Figure 1.11: Schematic of lipid raft domain contained within a bilayer. Blue lipids are POPC
or POPS. Symbol “-” indicates the negatively charged POPS. Green ovals labelled “C” indicate
cholesterol, orange lipids labelled “S” indicate sphingolipid, purple lipids labelled “G” indicate
gangliosides.
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Two lipid mixtures were used in the work presented in this thesis: soybean PC, and
brain total lipid extract (BTLE). Soybean PC is an extract from soybeans of all lipids
containing the PC head group. A variety of acyl chain lengths and unsaturation levels is
present in this mixture, but the predominant species is shown in Figure 1.12. BTLE is not
characterised by the suppliers, but a breakdown of the head groups present is given in Table
1.1. Soybean PC was chosen as an extract that is easy to handle at room temperature,
suitably soluble, and representative of some natural lipid membranes. BTLE was chosen
as ↵-synuclein is found mainly in the brain, and these lipids would be representative of
those it would encounter.
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Figure 1.12: The predominant species found in soybean PC extract.
Table 1.1: Proportions of lipid head groups found in brain total lipid extract.
Head Group wt/wt%
PC 9.6
PE 16.7
PI 1.6
PS 10.6
PA 2.8
Unknown 58.7
Total 100.0
1.4 Annular, amyloid oligomers
Oligomers of amyloid proteins have been introduced briefly in Section 1.1, but clarification
is needed to refine this concept and focus on those chemical species relevant to this work.
Kim et al. produced work characterising oligomers they derived from broken-down fibrils
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of ↵-synuclein (Kim et al., 2009). It has long been suspected that the fibrillar aggregates
found in brains of PD su↵erers, as in other amyloid conditions, are not the most neurotoxic
species (Hardy & Selkoe, 2002). It is believed that soluble oligomers, formed either as an
intermediate to fibrils or formed on a separate pathway, are much more toxic to cells. The
similarities in the oligomers led to the view that the amyloid proteins may share a method
of toxicity (Kayed et al., 2008). As such, this paper investigated properties of soluble
oligomers that may form pores in neurones, thereby leading to cell death. The oligomers
used in this study were not representative of those that are to be used in the present work,
however, there may be useful insights to gain from the Kim et al. approach, certainly with
regard to techniques employed in the characterisation.
Techniques used to probe the structure of the oligomers included Atomic Force Microscopy
(AFM), Transmission Electron Microscopy (TEM), Polyacrylamide Gel Electrophoresis
(PAGE), Dynamic Light Scattering (DLS), Circular Dichroism (CD), Nuclear Magnetic
Resonance (NMR), and small angle X-ray scattering (Kim et al., 2009; Sweers et al., 2012;
Lorenzen et al., 2014). Some of these techniques were combined by Kim et al. to assess
the size of the oligomers, whether they would form pores in membrane, and whether they
maintained fibrillar characteristics in oligomeric species. The oligomers were prepared by
breaking up fibrils, and were shown by Thioflavin T (ThT) fluorescence to easily re-form
fibrils, so these were defined as “on-pathway” oligomers: an intermediate step before full
fibrils are formed. Other oligomers can be synthesised that would never lead to fibril
formation. These would be known as o↵-pathway oligomers (Kim et al., 2009).
Antibody A11 has been shown to bind to neurotoxic oligomers in a sequence-independent
manner; i.e. they bind to the protein in this configuration regardless of which protein is
involved (Kayed et al., 2008). This is down to a very similar structure; as one group puts it,
the proteins form “morphologically indistinguishable annular protofibrils” (Lashuel et al.,
2002b). Kim et al. succeeded in showing that the antibody bound the oligomer they
had synthesised, but not monomer or fibril, confirming that this species was of the toxic
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oligomer type they were seeking.
It was found by Yoshiike et al. that fully-assembled ↵-haemolysin (↵HL, a bacterial toxin)
heptamers were detectable by A11, suggesting strongly that they share a conformation
epitope with amyloid oligomers. This is intriguing, pointing to mechanisms of amyloid
toxicity, among other things. The group simultaneously detected A  during this experiment,
confirming that the A11 used was detecting the correct species. The human pore-forming
protein (PFP) perforin (released by cytotoxic T-lymphocytes and natural killer cells) was
also shown to be detectable by A11, again showing that its mode of action might be very
similar to the mode of toxicity of amyloid proteins (Yoshiike et al., 2007).
The aggregation of ↵HL and perforin were compared to that of A  by the ThT fluorescence
assay discussed earlier. It was expected that the change in fluorescence would be similar
for all three, but the two non-amyloid proteins did not show the characteristic amyloid
aggregation ThT curve, perhaps due to limitations of the assay. However, by electron
microscopy, it could be confirmed that oligomers resembling amyloid rings were present
in samples of ↵HL, and even structures resembling amyloid fibrils were seen in perforin
samples. This gives further clues to the similarities between amyloid proteins and PFPs
(Yoshiike et al., 2007).
Several groups have been able to show that ↵-synuclein oligomers were able to form
well-defined pores in lipid membrane (as other amyloid proteins have been shown to do)
(Lashuel et al., 2002b; Danzer et al., 2007; Kim et al., 2009). This is a suspected method
of toxicity, since pores would change the environment of the cell leading to incorrect
concentrations of metabolites and other ions. Interestingly, despite Kim et al. breaking
down fibrils to form their oligomers, it was shown by solid-state NMR that the small
oligomers are not fibrillar. This was confirmed by TEM and AFM, in which no fibrils were
seen, and is reflected in experiments on A  (Kim et al., 2009).
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1.5 Oligomer preparation
It is important to reinforce that oligomers used in the Kim et al. study were made in an
entirely di↵erent way to the oligomers that will be used in this project. These oligomers
may in fact be more correctly classed as protofibrils, since it is likely that the change from
oligomer to fibril requires a major structural change. An oligomer of the type we require
would not go on to form a fibril, but would be o↵-pathway. Our oligomers are formed
in vitro from a solution of monomer, and are stable enough not to form fibrils, even over
time, when frozen. Therefore, we conclude that the species is not on the same pathway.
Indeed, several oligomer preparations have been reported, resulting in di↵erent secondary
and tertiary structures (Lashuel et al., 2002b,a; Danzer et al., 2007; Kayed et al., 2008;
Kim et al., 2009).
Various preparations of ↵-synuclein oligomers have been reported. Apetri et al. describe
a method involving incubation at 37  C, until aggregates had formed, detected by AFM.
This method would lead to many species being formed, but the authors mainly discuss
spheroidal oligomers. These were separated from the mixture by filtration centrifugation
(Apetri et al., 2006).
Danzer et al. describe another oligomer preparation. The lyophilised protein is resuspended
in sodium phosphate bu↵er, with ethanol at low concentration. Depending on their
required product, the group may add FeCl3, or may leave this out. They use three
modifications to the protocol, involving agitation and incubation for di↵erent lengths of
time. They do obtain annular oligomers from these protocols (Danzer et al., 2007).
The method used by the Lansbury group to prepare ↵-synuclein oligomers, has been
adapted for use in the present work (Lashuel et al., 2002b,a). Briefly, according to the
original procedure, freeze-dried protein aliquots were resuspended in phosphate-bu↵ered
saline (PBS) to a concentration of 300 – 700µM. After an hour incubation on ice, the
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solution was refrigerated for up to four weeks. Regular samples were taken and subjected
to immunoblot using A11 antibody. This allows the progress of oligomerisation to be
monitored over time. When the A11 blot is successful (indicating successful oligomerisation),
the sample is separated by size-exclusion chromatography, using a gel filtration column.
1.6 Recent development
Bartels, Choi, and Selkoe recently challenged common knowledge of ↵-synuclein – the
belief that the native state of the protein is an unfolded monomer until it binds lipid. The
authors examined evidence that may show that the true native state of ↵-synuclein is a
helically-folded tetramer (Bartels et al., 2011). This is at odds with evidence gathered up
to this point, however, the authors argue that this is due to the use in previous research
of recombinant (as opposed to human) ↵-synuclein. The experiments performed to back
up this claim were thorough. Several cell lines were chosen that all express ↵-synuclein
endogenously: M17D (neuroblastoma cell line), HEK293 (embryonic kidney cells), HeLa
(human cancer cell line) and COS-7 (simian kidney cell line). In addition, mouse cortex
and fresh human red blood cells were used, since they too express ↵-synuclein.
Through various forms of gel electrophoresis (SDS-PAGE both with and without in vitro
cross-linkers, CN-PAGE and BN-PAGE) a non-denatured species with molecular weight
⇠45–50 kDa was identified. Coomassie blue stain may have e↵ects on protein migration
through gels, however, and under CN-PAGE the main species in all cell types had molecular
weight ⇠55–60 kDa. Since we know that the molecular weight of an ↵-synuclein monomer
is approximately 14.8 kDA, the detected mass corresponds very well to a tetramer. Other
analyses, including ultracentrifugation, confirmed that the average mass of ↵-synuclein
species in the cells was just over 55 kDa. By circular dichroism, the structure of these
tetramers was found to be strongly ↵-helical. The authors compared this to recombinant
↵-synuclein and confirmed that it exists as an unfolded monomer. When exposed to
26
CHAPTER 1. INTRODUCTION
PC/PS lipid, both species were ↵-helically folded (Bartels et al., 2011).
Wang et al. also reported data seeming to show a tetramer, this time in recombinant
↵-synuclein (Wang et al., 2011). This group expressed ↵-synuclein as a Glutathione S-
Transferase (GST)–fused protein, and required the GST tag to be removed for experiment.
They avoided denaturing conditions throughout their study. When purified on a size-
exclusion column, the construct used here eluted as a single sharp peak, with an apparent
molecular weight of around 56 kDa. Using chemical cross-linking, the group were also able
to show that four species are visible by SDS-PAGE, indicating the existence of tetramer.
Their analysis also found that the wild type construct here had ↵-helical structure by CD
spectroscopy. This was no longer the case after denaturation by heating. The Wang et al.
tetramer is shown in Figure 1.13.
Figure 1.13: The ↵-synuclein tetramer hypothesised by Wang et al., reproduced from Wang et
al., 2011.
In 2012, however, the Bartels et al. and Wang et al. papers were subjected to strong
criticism by a large collaborative publication including the group (Fauvet et al., 2012).
This study involved multiple groups, and multiple, independent, experiments, that all
failed to find the helical tetramer. Results from Fauvet et al. show that, as expected,
recombinant ↵-synuclein exists as a disordered monomer. With native, or heat-denaturing
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conditions, only disordered monomer was observed by a variety of methods. It was
suggested that the helical structure may have been observed by the other groups after
↵-synuclein had interacted with membrane and retained its altered structure. Fauvet et
al. examined this hypothesis by mixing the protein with lipid and observing its ↵-helical
structure by CD, then removing the lipid. After lipid removal the protein reverted to
disordered structure.
Secondly, ↵-synuclein purified from mouse and rat brains was shown to have similar
properties to recombinant ↵-synuclein. The unfolded recombinant monomer standard
ran to an apparent molecular weight of around 66 kDa on CN-PAGE. This was also seen
in several mouse and rat samples, indicating similar electrophoretic properties (size and
charge, for example). On SDS-PAGE all samples ran to the same molecular weight,
though this time around the expected monomer weight. It was also found that human
↵-synuclein (recovered from brain tissue post mortem), and ↵-synuclein derived from cell
lines (including HeLa and COS-7 amongst many others), migrated the same distance on
CN- and SDS-PAGE as unfolded monomer. Various expressions of the protein were shown
to elute from gel-filtration columns at the same elution time as native ↵-synuclein, and
heating did not alter this property, suggesting further that the proteins behave similarly
(Fauvet et al., 2012).
Whether the tetramer is the native form of ↵-synuclein, or whether it is a step on the
pathway to fibrils or oligomers, is not yet known. Data presented by Bartels et al. and
Wang et al. revealing the existence of the tetramer are compelling, but so are the data
presented by Fauvet et al. disputing the tetramer. While the studies presented in this
thesis did not actively seek tetrameric structure, all researchers in the ↵-synuclein field
have become aware of this potential species, and its putative roles in pathways to toxic
species. One point that is very clear, though, is that structural studies are essential
for work on understanding ↵-synuclein, and structural work requires robust, validated
techniques in order to be accepted by the field.
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1.7 Melittin
A second protein was used in the studies presented here to provide comparisons and context
for ↵-synuclein data. Melittin is known as the major component of bee venom, and up-
regulates phospholipase A2. It has cell membrane lysis abilities in some circumstances
(Terwilliger & Eisenberg, 1982a,b; Pettersen et al., 2004). This protein has been studied
by various laboratories, including the Rodger laboratory, its structure measured by CD,
and its linear dichroism (LD) spectra have been reported (Sui et al., 1994; Damianoglou
et al., 2010; Svensson et al., 2011). Like ↵-synuclein, the secondary structure of melittin
changes when it interacts with membranes. The structure of the melittin dimer (adopted
in lipidic environments) is shown in Figure 1.14. The change in structure exhibited by
melittin, and its previously-studied LD make it ideal as a tool with which to verify and
calibrate the CD and LD methods applied in this work.
Figure 1.14: Structure of melittin in lipid environments. Image prepared using Chimera, and
coordinate file downloaded from the protein database, PDB ID: 2MLT.
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1.8 Techniques used in these studies
It has been emphasised above that key to understanding the toxicity of amyloid proteins,
is understanding the interactions they make with membranes. This has implications for
whether they form pores in organelles or vesicles, whether they transport vesicles at or
near the synapse, or whether their role is elsewhere. Spectroscopic techniques have been
used in studies discussed above, and these were judged to be the most appropriate in this
work. Since vesicles would be used, studies were undertaken into the behaviour of such
lipid structures, especially in flow. Circular dichroism was used as the most appropriate
way to track changes in the secondary structure of the proteins. Tryptophan fluorescence
was chosen as this technique is very sensitive, and allows a single region of the protein to
be monitored during interaction with the membrane. Finally, linear dichroism was used
as it provides data that complements the other spectroscopic techniques and is, as yet,
underused by the field.
1.8.1 Vesicle behaviour studies
This project includes work carried out in order to understand some of the processes that
occur when Couette flow is applied to lipid vesicles, and therefore improve spectroscopic
work using protein-lipid systems. By monitoring the leakiness of vesicles, it was possible
to determine how damaging the e↵ects of Couette flow are on these structures. Calcein
leakage was chosen as an easily-measured indicator of vesicles permeability, as demonstrated
in literature for many years (Calissano et al., 1972; Papahadjopoulos et al., 1973; Gliozzi
et al., 2002; Jesorka & Orwar, 2008). Calcein fluorescence is di↵erent when packed into a
vesicle at high concentration, and when in dilute solution, so by monitoring fluorescence
emission during an experiment it is possible to draw conclusions about the stresses a vesicle
is under.
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McLachlan et al. developed methods for determining the alignment of vesicles in Couette
flow. Here, this method was combined with some straightforward mathematical modelling,
determining the geometry adopted by vesicles in shear flow. This gave an experimentally
verifiable indicator of the degree to which a vesicles must change shape in order to adapt
to the strong shear flow used in linear dichroism measurements.
The e↵ect of flow on vesicles has also been studied previously, but mostly by theoretical
means, and with little application to relevant studies (de Haas et al., 1997; Noguchi &
Gompper, 2005; Mader et al., 2006; Kaoui et al., 2009; Deschamps et al., 2009; Bagchi &
Kalluri, 2009). While this work is doubtless essential to the field at large, questions about
whether certain lipids should fare better in a linear dichroism experiment, for example,
have hardly been touched on. It was possible in this work to combine much more basic
modelling with experimental results, and determine some fundamental points about using
vesicles in these kinds of experiments.
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1.8.2 Intrinsic tryptophan fluorescence
Fluorescence occurs due to the excitation of a fluorophore through absorbance of light at a
specific wavelength. Absorbance describes the process of photons causing electrons in the
fluorophore to move to a di↵erent, higher, electronic state of higher energy. This energy
must be lost by the fluorophore as it returns to its ground state, and is lost in the form of
emitted photons at a di↵erent wavelength than those used to excite the fluorophore. This
process may be described by Figure 1.15.
Photons 
emitted 
Excitatory photons 
Figure 1.15: The principle of the process of fluorescence, demonstrating that absorbed photons
cause a change in energy level of fluorophore electrons, and as the fluorophore returns to ground
state other photons are emitted.
In the experiments described here, the fluorophore used is the amino acid tryptophan.
Tryptophan is known to emit fluorescence when excited by light at around 295 nm (Ladokhin
et al., 2000; Dusa et al., 2006; Pfe↵erkorn & Lee, 2010; Pfe↵erkorn et al., 2012). The
wavelength of the emitted light varies according to the environment of the tryptophan, so
monitoring this wavelength allows conclusions to be drawn about whether the tryptophan
has undergone some kind of environmental change. One such change is the burying of the
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residue in a lipid membrane away from aqueous solution, therefore allowing deductions
to be made about the interaction of the protein containing the tryptophan with a lipid
vesicle.
1.8.3 Circular dichroism and linear dichroism
Circular dichroism (CD) is long established as the technique of choice for determination
of protein secondary structure, not least in the field of amyloid proteins, as mentioned
in Section 1.2 (Sui et al., 1994; Kelly & Price, 1997; Davidson et al., 1998; Johnson,
1999; Eliezer et al., 2001; Munishkina et al., 2003; Martinez et al., 2007). Light is
circularly polarised in opposite directions, and the absorbance of this light in one direction,
subtracted from the absorbance of light in the opposite direction. A signal is observed,
therefore, when these absorbances are di↵erent – the case occurring for chiral molecules,
and molecules with chiral domains such as peptides and ↵-helices. It is possible to use
this technique to monitor the development of structure such as ↵-helix under di↵erent
conditions and draw conclusions about how these conditions influence the molecular secondary
structure. Protein secondary structures have characteristic CD spectra, demonstrated in
Figure 1.16, reproduced from an early computational CD study (Greenfield & Fasman,
1969).
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Figure 1.16: Computed, characteristic, CD spectra for the major protein secondary structure
types, reproduced from Greenfield and Fasman, 1969.
The characteristic bands observed in Figure 1.16 are usually seen in some kind of combination,
e.g. if a protein is partly disordered but partly ↵-helical, the ↵-helix band around 190 nm
will usually be much reduced or not present. Therefore, by monitoring the development of
particular bands, we may make inferences about the state of the overall structure.
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Linear dichroism (LD) is a lesser-used optical technique, related to CD, that measures
di↵erential absorbance of light by oriented molecules. When aligned, molecules containing
chromophores are more readily able to absorb light in some directions than others. LD
measures the di↵erence in absorbance of light polarised parallel to the direction of alignment,
and perpendicular to it. In this way, we gain insight into whether a system of molecules do
align, or whether, for example, a chromophore interacting with a vesicle surface is inserted
into the membrane or across it (Norde´n et al., 1992; Ardhammar et al., 1998; Rajendra
et al., 2004, 2006).
Figure 1.17 shows the expected position of LD bands for ↵-helices and  -sheet protein
structures interacting with vesicle membrane.
195 
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195 195 
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208 
208 
208 
208 
208 222 
222 
222 222 
222 
LD 
LD 
LD 
LD 
ON the surface Inserted, no 
cancellation 
Inserted, 
cancellation 
(a) 
(b) 
α-helix 
β-sheet 
Figure 1.17: Characteristic band positions for (a) ↵-helices, and (b)  -sheets interacting with
vesicle membrane. (Left) structures on the vesicle surface, (right) structures inserted across vesicle
membrane. For ↵-helix, the bands may cancel when the protein inserts into the membrane, hence
two sets of LD bands are shown. Figure based on figure from Norde´n, Rodger and Da↵orn, 2010.
The bands observed in CD and LD spectroscopy are due to the presence of the peptide
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bonds between each amino acid in the protein. These bonds contain bonding, non-bonding,
and delocalised electrons, the transitions of which occur at 210-230 nm (n   ! ⇡⇤), and
around 190 nm (⇡   ! ⇡⇤) (Norde´n et al., 2010).
Various groups have set out to use LD to gain insight into protein-lipid interactions,
following on from attempts to use oriented CD to determine protein orientation (de Jongh
et al., 1994). The CD technique has not been widely adopted, but LD has shown more
promise since it is more straightforward and more logical. An LD signal should be obtained
if several protein molecules align together on the surface of a vesicle, for example, or if
peptides cross the membrane, and insert parallel to lipid molecules. The first key step,
in an experiment of this nature, is to set up a system that encourages alignment. In this
case, Couette flow is used. Figure 1.18 demonstrates how this is achieved. The sample
chamber is a space between a hollow quartz capillary and a quartz rod. The capillary is
set to rotate, thereby generating flow in the sample bu↵er. Since the bu↵er is under flow,
long molecules in solution are encouraged to align in the direction of the flow.
Plane-polarised light is transmitted trough the sample in two orientations (parallel to the
direction of alignment, and perpendicular), and absorbance at each wavelength measured.
LD signal is calculated as:
LD = Ak  A?.
Deductions are made about the molecules in solution based on properties of the resulting
spectrum, such as whether bands are positive or negative, at what wavelengths bands
occur, etc. (Norde´n et al., 2010).
LD is extended by probing what happens to alignment when some extra condition is
applied to the molecules under study. In the case of membrane-interacting proteins, we
ask whether the protein lies across the surface of a vesicle, or if it might insert across
a membrane (Damianoglou et al., 2010). A vesicle under Couette flow is believed to
flatten, from its stable sphere conformation, into an ellipsoid, and an ↵-helical protein
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Figure 1.18: Schematic of LD cell generating alignment by Couette flow. Torque produced by
the rotating capillary induces long molecules to orient in the direction of flow. The capillary has
inner diameter 2.9mm, the rod has diameter 2.4mm. Both rod and capillary are optical-quality
quartz, so light may be shone through the cell at any angle.
on the surface ought to act as a stabilising rib, giving the ellipsoid an axis of alignment.
Therefore, a strong alignment signal should be seen for this sort of protein-membrane
interaction. The expected bands on such an LD spectrum would be positive at 195 nm,
negative at 208 nm, and positive at 222 nm. Conversely, if peptides insert across the
bilayer, parallel to membrane normal, the LD bands would have opposite signs (Norde´n
et al., 2010).
There are technical issues with LD, however, that have hindered progress in the past.
LD of membrane protein depends on a reliable membrane system, and does not give
reproducible results if the membrane vesicles are unstable. Another issue is the as-yet
poorly understood nature of vesicle deformation under flow – just how the shape of the
vesicle changes, and how this a↵ects its volume or surface area, is not known. This project
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uses a combination of experimental and theoretical approaches, in order to establish how
volume and orientation of vesicles may change in di↵erent conditions of flow. Probe
molecules may be added to lipid preparations in order to indirectly measure the LD of
the vesicles themselves. Probes may interact with the lipids in two ways, shown in Figure
1.19.
β
Membrane 
normal 
Transition moment Transition 
moment 
Figure 1.19: Schematic of small molecule-membrane interactions, and their relationship to
the membrane normal. On the left is anthracene. In this case, its transition moment being
perpendicular to membrane normal, and therefore its angle   being 90 . On the right is
diphenylhexatriene, with its major transition being parallel to membrane normal, and angle  
being 0.
Vesicles in flow are compressed in the direction of the flow, i.e. they develop long sides
and short sides (Mader et al., 2006). If a probe, such as the diphenylhexatriene shown in
Figure 1.19, is uniformly incorporated into the lipid mixture there would be no LD signal
until an orientation force was applied by Couette flow, as positive and negative signals
in the bulk suspension would cancel each other out. In flow, there would be more probe
molecules along the long sides of the vesicles, therefore resulting in LD signal.
1.9 Work presented in this thesis
There were several objectives to this work. These overlap, and provide insights for
researchers at the interface of amyloid protein biochemistry and spectroscopy. In order
to understand amyloid toxicity it is necessary to fully understand the way the proteins
interact with lipid membranes, and therefore one must understand the lipids themselves.
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The studies presented in this thesis include theoretical and experimental investigations
into vesicles behaviour, CD, LD, and fluorescence investigation into ↵-synuclein–lipid
interaction, and work done to improve LD itself. The work was broken-down into the
following themes:
• Develop the practical knowledge of vesicle behaviour in flow
The theoretical literature on lipid vesicles in flow is extensive, but does not translate
into e↵ective practical work, especially in a Couette flow system. This work aims to
take current knowledge and laboratory experience and extend it. Some theoretical
work is described in order to understand the expected dimensions a vesicle would
achieve during flow, and how this would a↵ect its volume. Experimental work was
also carried out to measure how resilient vesicles of di↵erent types are in Couette
flow – only those that can withstand Couette flow for extended periods are suitable
for linear dichroism.
• Use tryptophan fluorescence to study ↵-synuclein–lipid interaction
The ability of ↵-synuclein to bind lipid vesicles has been investigated previously,
but certain lipids (POPC, POPS, GM1, SM1, cholesterol) have not been studied in
depth. It is important, if the true role of ↵-synuclein in health or disease is to be
understood, that any plausible interaction is studied in some detail. By using an
inserted tryptophan as a reporter of protein environment, the data presented in this
thesis aim to explain the interaction of the protein with POPC and POPS in much
more detail than previously known. GM1, SM1 and cholesterol are also investigated
for any e↵ect on the binding.
• Use circular dichroism to study melittin and ↵-synuclein–lipid interaction
By using the same preparations of protein and lipid as for fluorescence studies, much
more information on these interactions is gained through making circular dichroism
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measurements of the samples. The work presented here shows how the rate structural
change undergone on lipid binding is similar to the rates of change in fluorescence,
indicating that the two processes occur in parallel.
Melittin was used in these studies as a model protein, well-known to biophysics. In
the experiments presented here, CD of melittin was pushed to technically challenging
levels, measuring CD spectra in the LD cell. By demonstrating that this experimental
set-up was able to deliver good quality CD, this work has opened new experimental
options for other protein-lipid systems. This approach was then applied to ↵-
synuclein, both its monomeric and oligomeric forms. This CD data is an essential
partner to the LD data also gathered.
• Develop robust methodology for protein–lipid interaction linear dichroism
studies
At times, researchers have achieved good LD data for proteins and lipids, and at
other times the data has been poor. Much of the lower quality data may be attributed
to poor sample preparation or unsuitable lipid selection. The final aim of this work
was to report on the successes achieved here in generating meaningful LD spectra,
and how sample preparation and lipid selection influenced the spectra. By first
using melittin, the well-studied model peptide, the data reported here validate the
methodology used as appropriate and sound. This method was then applied to ↵-
synuclein, giving a simple spectroscopic measurement of oligomeric amyloid protein
interacting with lipid membranes for the first time.
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Experimental
2.1 Introduction
The reasons and motivations for researching ↵-synuclein are discussed in Chapter 1,
enabling the design of experiments presented in this chapter. The techniques selected
were predominantly spectroscopic, and often represent extensions of techniques used in
the literature. Circular dichroism is a crucial tool in structural biology, giving secondary
structure information. By monitoring changes in secondary structure, researchers have
been able to shed light on many protein-based systems, including amyloid folding and
misfolding (Sui et al., 1994; Kelly & Price, 1997; Davidson et al., 1998; Johnson, 1999;
Eliezer et al., 2001; Munishkina et al., 2003). In this study, it was necessary to monitor
the change in the secondary structure of ↵-synuclein as it interacts with lipids, making
CD an ideal technique.
Intrinsic tryptophan fluorescence has been used in many previous studies, since this amino
acid has a strong fluorescence emission that changes in response to its environment. This
is also an established technique in protein folding studies, both for amyloid research and
other categories of protein biophysics (Ladokhin et al., 2000; Dusa et al., 2006; Pfe↵erkorn
& Lee, 2010; Pfe↵erkorn et al., 2012). Wild type (WT) ↵-synuclein has no tryptophan
residues, so the insertion of a single Trp is discussed in this chapter.
Linear dichroism, as yet, has a smaller field of associated research, but its use here has been
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essential in extending the tools available for studying protein-lipid interactions. These
methods are developments from those previously utilised in the Norde´n, Rodger, and
Da↵orn laboratories (Rodger & Norde´n, 1997; Rodger et al., 2002; Norde´n et al., 1992,
2010).
In this study, E46K ↵-synuclein is compared to ↵-synuclein without the E46K mutation on
a structural level, and through interactions with lipids. The protein was required in large
quantities (on the order of tens of milligrams), and this was achieved by expressing the
protein in Escherichia coli. The methods presented here draw on laboratory experience
and knowledge, as well as that of other groups, to produce an e cient expression process
for two constructs of ↵-synuclein, Y39W, and E46K:Y39W (Lashuel et al., 2002b,a).
Work by Timothy Kaufmann and Rachel Smith in the Pinheiro laboratory has led to
an improvement in production of ↵-synuclein oligomers, the method for production of
which is detailed below, and this process has been employed for the material for our LD
studies.
2.2 Materials and methods
2.2.1 Materials
Consumables procured
The following were obtained from Abcam (Cambridge, UK): Full length wild type human
↵-synuclein for control experiment.
From Agilent (Santa Clara, CA, USA): Stratagene site-directed mutagenesis QuikChange
II kit.
From Avanti Polar Lipids (Alabaster, AL, USA): POPC, DPPC, DMPC, POPS, BTLE,
SM1, soybean PC.
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From Bio-Rad (Hercules, CA, USA): Bradford assay reagent, SDS-PAGE kit, SDS-PAGE
low molecular weight protein markers.
From Integrated DNA Technologies (IDT) (Coralville, IA, USA): DNA primers, IDTE
bu↵er.
From Invitrogen (Carlsbad, CA, USA): SYBR Safe DNA gel stain
From Melford (Ipswich, UK): Tris, IPTG.
From Merck (Kenilworth, NJ, USA): MgCl2, yeast extract, pepton.
From National Diagnostics (Atlanta, GA, USA): 30% acrylamide mixture.
From QIAGEN (Limburg, Netherlands): QIAprep miniprep kit, QIAquick Gel Extraction
kit.
From Severn Biotech (Kidderminster, UK): Coomassie Blue G-250.
From Sigma-Aldrich (Poole, Dorset, UK): RbCl, CaCl2, MgSO4, MnCl2, bromophenol
blue, phosphoric acid, 3-(N-morpholino)propanesulfonic acid (MOPS), GM1, sepharose
4B N,N,N0,N0-tetramethylethane-1,2-diamine (TEMED), Ethylenediaminetetraacetic acid
(EDTA), Phenylmethylsulfonyl fluoride (PMSF), calcein, diphenylhexatriene (DPH), N-
[Tris(hydroxymethyl)methyl]-2-aminoethanesulfonic acid (TES).
From Thermo Fisher Scientific (Waltham, MA, USA): NaH2PO4, Na2HPO4, NaCl, (NH4)2S2O8,
(NH4)2SO4, CH3CO2K, KH2PO4, K2HPO4, glycine, glycerol, 2-mercaptoethanol, sodium
dodecyl sulphate (SDS), snake skin pleated dialysis tubing (3,500 MWCO), DNA standard
1 kb ladder, 6⇥ DNA loading dye solution.
Bu↵ers and solutions prepared in the laboratory
For cell culture
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Lysogeny broth (LB): 10 g peptone, 5 g yeast extract, and 10 g NaCl, made up to 1L with
distilled water, and autoclaved to sterilise.
Terrific broth (TB): 12 g peptone, 24 g yeast extract, 4mL glycerol, made up to 900L with
distilled water, and autoclaved to sterilise. 100mL of TB salts solution contained: 0.17M
KH2PO4, and 0.72M K2HPO4, autoclaved. The two components were mixed on day of
use.
For competent cell production
TFB1: 30mMCH3CO2K, 10mMCaCl2, 50mMMnCl2, 100mMRbCl, 15% (v/v) glycerol,
pH 5.8.
TFB2: 10mM MOPS, 75mM CaCl2, 10mM RbCl, 15% (v/v) glycerol, pH 6.5.
For SDS-PAGE
Resolving gel: 375mM Tris pH 8.8, 15% acrylamide, 0.1% SDS, 0.1% (NH4)2S2O8,
0.0004% TEMED.
Stacking gel: 100mM Tris pH 6.8, 5% acrylamide, 0.1% SDS, 0.1% (NH4)2S2O8, 0.0004%
TEMED.
Sample bu↵er: 62.5mMTris-HCl pH 6.8, 10% (v/v) glycerol, 2% SDS, 5% 2-mercaptoethanol,
0.05% bromophenol blue.
Running bu↵er: 25mM Tris base, 192mM glycine, 0.1% SDS, pH 8.3.
Colloidal Coomassie blue stain: 10% (NH4)2SO4, 0.1% Coomassie G250, 20% ethanol,
3% phosphoric acid.
For purification and fast protein liquid chromatography (FPLC)
Lysis bu↵er: 10mM Tris-HCl, 1mM EDTA, 1mM PMSF, pH 8.0.
Bu↵er A: 10mM Tris-HCl, pH7.4. Filtered and degassed on day of use.
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Bu↵er B: 10mM Tris-HCl, 2M NaCl, pH 7.4. Filtered and degassed on day of use.
Phosphate-bu↵ered saline (PBS): 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM
KH2PO4.
Sodium phosphate bu↵er: 10mMmixture of Na2HPO4 and NaH2PO4, mixed at proportion
resulting in pH of 7.4.
2.2.2 Expression of ↵-synuclein
Preparation of competent cells
E. coli strain BL21* Rosetta cells from Dr Kelly Walker (University of Warwick) were
were streaked onto an LB agar plate, and incubated overnight at 37  C. These cells have
resistance to chloramphenicol, so any E. coli growth in chloramphenicol-containing media
should occur only from this strain, allowing selection from wild type bacteria. Single,
typical, E. coli colonies were selected with which to inoculate 2.5mL of LB medium1.
These cultures were incubated overnight at 37  C with shaking at 160 rpm. The entire
overnight culture was added to 250mL LB containing 20mM MgSO4, and grown at 37
 C
with shaking at 160 rpm until the optical density at 600 nm (OD600) was between 0.4
and 0.6. The cells were harvested by centrifugation at 4,500 g for 5minutes at 4  C, and
the pellet resuspended in 100mL ice cold TFB1. The centrifuge step was repeated, with
resuspension in 10mL ice-cold TFB2. After 30minutes incubation on ice, the cells were
transferred to 200µL aliquots, and flash frozen with dry ice, for storage at – 80  C.
1Typical E. coli colonies were defined as 1-3mm white-yellow circular colonies on LB agar plates, after
overnight incubation.
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Expression plasmid
The PGS-21a plasmid encoding ↵-synuclein with Y39W insert was obtained from Prof. Fiona
Benson (Lancaster University). The gene is controlled by a T7 promotor, and expression
was initiated by the addition of IPTG. In order to be used for mutagenesis, the plasmid
was amplified by expression in E. coli. This plasmid confers resistance to the antibiotic
ampicillin, enabling the use of this antibiotic as a selective tool: any E. coli growth in
media containing ampicillin would be from bacteria containing this plasmid.
The plasmid was defrosted on ice for 2 minutes and 1µL was mixed with 100µL of
competent E. coli strain DH5-↵ from Pinheiro laboratory stocks, prepared similarly to the
method for BL21* above. After incubating on ice for 30minutes, the cells were exposed
to heat shock at 42  C for 45 seconds, followed by incubation on ice for 2minutes. After
adding 900µL of LB, to give a total volume of 1mL, the cells were incubated for 1 hour
at 37  C. The cells were then centrifuged at 5,000 g for 2minutes. The supernatant was
discarded and the cells resuspended in 100µL of LB, then plated onto LB agar with
ampicillin at 100µg/mL, to be incubated overnight at 37  C. One colony was transferred
to 5mL of LB with ampicillin at 100µg/mL and incubated overnight at 37  C with
shaking.
The plasmid template was purified from the DH5-↵ strain E. coli using a QIAprep
Miniprep Kit (QIAGEN, Netherlands). PCR mutagenesis was carried out by Anthony
Wambua in the Pinheiro laboratory as detailed below, resulting in the production of
E46K:Y39W to complement the Y39W construct.
Site-directed mutagenesis
Primers for PCR mutagenesis were designed manually using sequence data supplied by
the manufacturer for the PGS-21a plasmid. Forward and reverse primers were designed
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with seven codons flanking the inserted mutation on either side. Primers were supplied
by Integrated DNA technologies (IDT, USA) and had the following sequences:
1: 50–TGG GTC GGC TCT AAA ACG AAA2 AAA GGC GTG GTG CAT GGC GTG
GCG–30
2: 50–CGC CAC GCC ATG CAC CAC GCC TTT TTT CGT TTT AGA GCC CAC
CCA–30
The concentration of the primers obtained was 100µM in 285µL IDTE bu↵er pH8.
10 pM/µL solutions of each primer were prepared, and mixed according to Table 2.1.
Table 2.1: Quantities of reagents used in PCR mutagenesis.
Reagent Volume (µL)
Sterile water 39.0
10x bu↵er 5.0
dNTPs 1.5
Primer 1 1.5
Primer 2 1.5
Template 0.5
PfuUltra DNA polymerase 1.0
The PCR cycle was performed according to the Stratagene site-directed mutagenesis
QuikChange II kit (Agilent, USA). PCR was performed overnight, with the following
steps: Parental DNA was denatured at 95  C for 30 seconds, followed by 18 cycles of 95  C
for 30 seconds and 55  C for 1minute, in order to denature parental DNA and anneal the
primers. This stage was followed by 68  C for 1minute/kb plasmid length, plus 5minutes,
to allow complete extension of primers.
PCR products were purified from other DNA by extraction from agarose gel. 2 g of high-
melting point agarose was added to 250mL TAE (40mM Tris acetate, 1mM EDTA) giving
a 0.8% (w/v) agarose solution. This was heated by microwave oven until all the agarose
had dissolved, then allowed to cool until safe to handle. 25µL of 10,000⇥ SYBR Safe DNA
2This AAA codon in the forward primer encodes lysine. It is di↵erent by a single nucleotide to the wild
type GAA codon for glutamic acid.
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gel stain was added (Invitrogen, USA), and the gel was poured into the relevant mould to
set. Once set, the gel was submerged in the gel tank in 1⇥ TAE. DNA was loaded with 6⇥
DNA loading dye solution in a 5:1 ratio. 5µL of DNA standard 1Kb ladder was loaded
into a lane for size comparison. Electrophoresis was performed at 100V for 40minutes,
and the gel was visualised using ultraviolet light on a GeneSnap gel illuminator system
(Syngene, India). The correct PCR product was excised with a razor blade, then purified
by QIAquick Gel Extraction kit (Agilent, USA).
Expression and purification of ↵-synuclein
A 200µL aliquot of competent E. coli BL21* Rosetta cells were thawed on ice. 1µL of the
relevant plasmid solution (Y39W or E46K:Y39W) was added, and the mixture incubated
for 30minutes on ice. The mixture was exposed to heat shock of 42  C for 60 seconds,
then incubated for 2minutes on ice. This mixture was added to 3mL of LB medium
and incubated for 45minutes at 37  C with shaking at 160 rpm, then spread onto an LB
plate with ampicillin at 100µg/mL and chloramphenicol at 20µg/mL. The plates were
incubated at 37  C overnight.
Single, typical, E. coli colonies were picked from the plates, and used to inoculate 10mL of
LB with ampicillin at 100µg/mL and chloramphenicol at 20µg/mL. These starter cultures
were incubated overnight at 37  C with shaking at 160 rpm. The following day, individual
starter cultures were added to 1L TB in 2L flasks. These were incubated at 37  C with
shaking at 160 rpm until the OD600 was between 0.4 and 0.6. At this point, 1mL 1M IPTG
was added to the flask to induce expression of ↵-synuclein. Incubation was continued for
4 hours, and the cells harvested by centrifugation at 10,000 g, the supernatant discarded
and the pellet frozen.
The pellet was resuspended in 15mL lysis bu↵er. Cell lysis was performed by freeze-
thawing, followed by sonication. After another centrifugation step, the supernatant was
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collected. The supernatant was made up to 60mL with Tris bu↵er at pH 8.0, and placed,
in a flask, in a water bath at approximately 100  C for around 10minutes. Depending
on cell density, a more-or-less visible film of proteins precipitated out around the flask.
Ammonium sulfate was added to 50% saturation, causing more proteins, ↵-synuclein
included, to precipitate. After centrifugation, and re-suspension of the pellet in in Tris
bu↵er at pH 7.4, a solution was obtained containing all the ↵-synuclein, with some
impurities.
The protein was purified by FPLC, first using a Source 30Q anion exchange column
(GE Healthcare, UK), then determining by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) in which fractions the ↵-synuclein had eluted. Anion exchange
used bu↵ers A and B described in Section 2.2.1. Bu↵er A was the bu↵er used to load
protein onto the column, and bu↵er B as the elution bu↵er, was incorporated on a
gradient up to 35% over 150mL. Anion exchange fractions that contained ↵-synuclein
were pooled, freeze-dried, and dialysed into 0.01M sodium phosphate bu↵er, pH 7.4, using
Snake skin pleated dialysis tubing. The sample was then put through a second round
of chromatography, this time by Sephacryl S-300 high-resolution size-exclusion column
(GE Healthcare, UK), SDS-PAGE performed, ↵-synuclein-containing fractions pooled,
and dialysed again into 10mM sodium phosphate bu↵er at pH 7.4.
Characterisation of purified ↵-synuclein
At various stages of expression and purification, expression of ↵-synuclein was analysed
by SDS-PAGE. The protein was over-expressed, thanks to the T7 promotor and addition
of 1mM IPTG, and has a known molecular weight of around 14,440 kDa. The position
and relative size of the over-expressed protein band on the gel allowed a crude first test of
whether expression had been successful or not.
SDS-PAGE was performed by diluting 20µL of protein sample with 20µL sample bu↵er,
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before heating the samples to 90  C for 5minutes. The samples were loaded onto a
15% polyacrylamide gel, made using the solutions outlined in Section 2.2.1. The gels
were stained by colloidal Coomassie blue staining solution overnight to visualise the
proteins.
Since this stage of the protocol was completed before carrying out other checks, E. coli
were judged to have expressed ↵-synuclein when the characteristic over-expression band
was observed on SDS-PAGE gel of total cell extract. SDS-PAGE was carried out using
the solutions described in Section 2.2.1, and using SDS-PAGE gel casting equipment from
Bio-Rad (Hercules, CA, USA). Electrophoresis was performed at 170V for around 1 hour,
or until the sample bu↵er approached the base of the gel. 20µL of sample was loaded into
each well, 10µL of protein markers were loaded into one lane on each gel used.
Figure 2.1 shows images taken of SDS-PAGE gels onto which total cell extracts were
loaded. These cells had been transformed with ↵-synuclein containing one or two mutations:
one with Y39W (tyrosine to tryptophan), and one with Y39W and E46K (glutamic acid to
lysine), referred to as E46K:Y39W. The purpose of these gels was to demonstrate that over-
expression had taken place, demonstrated by swelling around 17 kDa (the characteristic
SDS-PAGE position for ↵-synuclein) and overspill and smearing.
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Figure 2.1: Polyacrylamide gels for a typical expression of (left) E46K:Y39W ↵-synuclein, and
(right) Y39W ↵-synuclein. Lanes shown are protein molecular weight markers, and cell extracts.
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Following each FPLC stage, various fractions were selected to be tested for ↵-synuclein
presence. These usually corresponded to peaks on the chromatogram. Examples of
chromatograms from which fractions were selected for SDS-PAGE are shown in Figure
2.2. These are typical for both Y39W and E46K:Y39W expression, with no discernible
di↵erence observed by this method.
Buffer B percentage 
Fraction 1 
2 
3 
4 
5 
7 
1    2    3  4    5  6 
Figure 2.2: FPLC chromatograms for ↵-synuclein expression. (top) Anion exchange, with A280
in blue, % bu↵er B (2M NaCl) in green, fractions in red; (bottom) gel filtration, with A280 in blue,
fractions in red. Numbers noted on plots indicate fractions used in SDS-PAGE.
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The quality and purity of ↵-synuclein was monitored by SDS-PAGE at various stages,
demonstrating that purity was at acceptable levels only after gel filtration FPLC. E46K:Y39W
fractions taken from samples labelled 1-7 and 1-6 in Figure 2.2, were used for SDS-PAGE,
with the corresponding gels shown in Figure 2.3.
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M   1       2    3       4     5      6 
Figure 2.3: SDS-PAGE for fractions gathered after FPLC, for a typical expression of
E46K:Y39W ↵-synuclein: (left) anion exchange FPLC, (right) size exclusion FPLC. Lanes shown
are protein molecular weight markers, and FPLC fractions. Numbered lanes correspond to
numbered labels on chromatograms.
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Figure 2.4: SDS-PAGE for fractions gathered after FPLC, for a typical expression of
E46K:Y39W ↵-synuclein: (left) anion exchange FPLC, (right) size exclusion FPLC. Lanes shown
are protein molecular weight markers, diluted cell extract, collected waste, and fractions from
chromatography. The corresponding chromatograms are not shown in this thesis, as they are
indistinguishable from those for E46K:Y39W.
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Three methods were used to confirm that the expression product was in fact ↵-synuclein,
and not some E. coli protein: fluorimetry, CD, and ESI-MS.
Fluorescence spectra were recorded on either a Photon Technology International Master
Series spectrofluorimeter (PTI, New Jersey, USA), or a Jasco FP-6500 spectrofluorimeter
(Jasco, UK). Quartz cells of 4mm path length were used, and an excitation wavelength
of 295 nm (2 nm bandwidth). Emission spectra were recorded from 300 to 450 nm (2 nm
bandwidth), and 4 scans were averaged per spectrum. The corresponding appropriate
backgrounds were subtracted from the final spectra, i.e. for demonstrating ↵-synuclein
production, 10mM sodium phosphate bu↵er, pH 7.4 was used.
Fluorimetry is a very sensitive technique in the right circumstances. Both ↵-synuclein
constructs used here have an inserted tryptophan residue (Y39W), which gives a characteristic
fluorescence. When tryptophan is in aqueous solution, and excited with light at 295 nm,
the fluorescence it gives o↵ will have a maximum wavelength ( max) of around 350 nm.
Figure 2.5 shows the emission spectra for both expressed proteins, excited at 295 nm. The
spectra show strong fluorescence, with peaks around 350 nm. Recombinant ↵-synuclein
exists as a disordered monomer, exposing the inserted tryptophan residue to its solvent.
This, therefore, also suggests that the proteins expressed were Y39W ↵-synuclein, and
the Trp residues were exposed to the solution, as expected for unfolded protein. The
presence of the fluorescence peak for Trp shows that Trp is present and therefore if the
protein is ↵-synuclein it is the correct construct, however it does not prove presence of
↵-synuclein.
Circular dichroism spectroscopy (CD) was carried out using a Jasco J-815 Spectropolarimeter
(Jasco, UK) using a 1mm quartz cuvette (Optiglass Ltd., Hainault). Measurements
were typically carried out between 190 and 260 nm at room temperature. The scanning
speed was 100 nm/min, bandwidth 2 nm, response time 1 second, and a resolution 1 nm.
Typically, 8 accumulations were averaged per spectrum, and appropriate backgrounds
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subtracted from the final spectra. Figure 2.5 shows the CD spectra generated for both
recombinant ↵-synuclein constructs: Y39W, and the E46K:Y39W double mutant. Both
spectra conform to the characteristic spectrum for a random coil protein, with the strong
negative band around 200 nm. This is evidence that the proteins produced are both
constructs of monomeric ↵-synuclein, without structure in aqueous solution, as expected.
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Figure 2.5: (left) Fluorescence emission spectra for ↵-synuclein constructs excited at 295 nm.
Black circles are data points for the E46:Y39W construct, red triangles are data points for the
Y39W mutant. (right) CD spectra for the same samples. Presence of Trp fluorescence indicates
that the Y39W mutation has been successful.
The molecular weight of purified ↵-synuclein was confirmed by electrospray ionisation mass
spectrometry (ESI-MS). Samples were sprayed in 10% methanol in positive ion mode.
Analysis was carried out by the Warwick/Waters BioMedical Mass Spectrometry Facility
at the School of Life Sciences, University of Warwick. ESI-MS allows the most certain
quality check of the expression product, compared to the pseudo-quantitative results from
SDS-PAGE, for example. Examples of mass spectra from a typical ↵-synuclein expression
are shown in Figure 2.6, demonstrating that the purification process left one major protein
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at the expected molecular weights of 14458.6 and 14459.1Da.
Figure 2.6: Deconvoluted mass spectra gathered for one expression each of Y39W ↵-synuclein
(top), and E46K:Y39W ↵-synuclein (bottom). Regions are focused around primary product, at
approximately 14,400Da.
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The expression of ↵-synuclein was accepted as true from the cumulative evidence of DNA
sequencing (carried out by Anthony Wambua), picking colonies of E. coli selected by
antibiotic resistance, over-expression bands observed on gels, protein folding and fluorescence
as expected, and mass spectra as expected. The Pinheiro laboratory had produced ↵-
synuclein in preliminary work before this project, and confirmed the production of the
protein by Western blotting. This blotting was reproduced during the undergraduate
research project undertaken by Rachel Smith in the Pinheiro laboratory. Under my
supervision and instruction, Figure 2.7 was produced. The same expression and purification
methods described above were used to produce the protein.
Figure 2.7: (Top) SDS-PAGE and (bottom) Western blot of ↵-synuclein constructs following
purification by anion exchange and size exclusion chromatography. Lanes labelled M are protein
markers, WT are Y39W, ET are E46K:Y39W, E are E46K, and A are A53T. Reproduced with
permission of the author (Smith, 2013).
2.2.3 Monomeric protein-lipid binding experiments
Lipids provided as solids were dissolved in chloroform, or methanol if solubility in chloroform
was low. Lipids were mixed to the required molar ratios, then dried thoroughly under N2
or by rotary evaporation. The resulting films of lipid were desiccated overnight. They were
resuspended in sodium phosphate bu↵er at 10mM, pH 7.4. The resuspension volume was
56
CHAPTER 2. EXPERIMENTAL
such that the final concentration of lipid was 20mM. This suspension was sonicated until
clear – typically 30minutes. This provided enough energy over a long enough time period
to cause vesicles to convert from multi-lamellar to unilamellar structure.
CD measurements were made on protein-lipid samples, using the parameters noted above.
The subtracted background spectrum for each measurement contained the same amount of
lipid, but diluted with bu↵er, rather than protein solution. We were then able to plot CD
as a function of concentration of lipid, in the wavelength range of relevance for identifying
secondary structure: 190-260 nm.
Fluorescence measurements were made on protein-lipid samples, using the parameters
discussed above. The subtracted background spectrum for each measurement were obtained
using the same amount of lipid, but diluted with bu↵er, rather than protein solution. We
then plotted the shift in maximum emitted fluorescence ( max) as a function of lipid
concentration. A value of  max around 350 nm indicated that the protein was unfolded.
A value around 340 nm indicated that the tryptophan residue was in a hydrophobic
environment.
LD spectra were gathered using a Jasco J-815 spectropolarimeter (Jasco, Dunmow, UK)
adapted for LD by fitting with a Couette flow LD cell (Dioptica Scientific Ltd., Rugby,
UK). Flow was typically at a speed of 3000 rpm, with bandwidth of 2 nm. 8 accumulations
were made for each measurement, with non-spinning spectra taken as baselines.
2.2.4 Linear dichroism method development
The conditions described in this section represent starting points for the developments
in linear dichroism methods. These are typical experimental conditions, but are not
optimised for any specific system, particularly lipid and protein systems. In Chapter 6,
several conditions are described, leading to recommendations for more optimal methods.
57
CHAPTER 2. EXPERIMENTAL
Lipids supplied as solids were dissolved in chloroform or methanol, and then mixed as
needed. Lipids supplied as solutions in chloroform were mixed at appropriate molar ratios,
without further solvent addition. Diphenylhexatriene (DPH) was added to lipids for LD
at 1% w/w as an LD probe. The dissolved mixtures were dried in a rotary evaporator
resulting in a film of lipid around the inside of a round-bottomed flask. This took at least 2
hours. They were resuspended in appropriate bu↵ers, before being frozen at –20  C.
LD was carried out in Jasco spectropolarimeters: J-1500, J-815, J-720 (Jasco, Dunmow,
UK). These were adapted for LD by fitting with Couette flow cells (Dioptica Scientific
Ltd, Rugby, UK) (Marrington et al., 2004). A schematic of a Couette flow cell for LD
is shown in Figure 1.18. The width of the sample chamber (between stationary rod and
rotating capillary) was 250µm. Spectra were initially measured between 190 and 260 nm,
later between 180 and 500 nm. Rotation speed was 3000 rpm. Typically, spectra were the
average of 8 accumulations. The lipid resuspension bu↵er in this case was 10mM sodium
phosphate, pH 7.4.
2.2.5 Vesicle leakage studies
Vesicle leakage experiments were carried out in a Bio-Logic MOS-450 spectrometer (Bio-
Logic, Claix, France) fitted with a Couette flow cell as for LD. Fluorescence of calcein over
time, with or without Couette flow at 3000 rpm, was recorded. The lipid resuspension
bu↵er in this case was 0.1mM EDTA, 10mM TES, 50mM calcein.
The dimensions of a compressed vesicle under Couette flow were approximated by a capsule
shape – a cylinder with hemispherical ends – and the method of McLachlan et al. applied
in MATLAB to calculate orientation of the vesicle (MATLAB, 2013; McLachlan et al.,
2013).
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2.2.6 Preparation of oligomeric ↵-synuclein
While interactions of monomeric amyloid proteins with membranes are interesting and
may answer questions about their role in diseases, it is oligomeric forms of these proteins
that are presently believed to be the most cytotoxic. In the present work, oligomeric
↵-synuclein was studied by CD and LD, while interacting with lipid membranes.
To prepare oligomeric ↵-synuclein, freeze-dried protein was resuspended in PBS containing
0.01% w/w sodium azide, to a final concentration of approximately 12mg/mL. This
preparation was incubated at 37  C at 900 rpm for 3 hours using a Thermomixer (Eppendorf,
Germany). The solution was subjected to ultracentrifugation at 100,000 g for 10minutes,
and the supernatant purified by FPLC. Using a Superdex 200 FPLC column, two distinct
peaks are observed: one for oligomer, and a later, larger peak for monomeric protein.
A chromatogram of this stage is shown in Figure 2.8. This protein may be collected
and allowed to oligomerise again. The fractions collected for the oligomer peak were
concentrated using Amicon centrifugal filters (Sigma-Aldrich, UK), 3 kDa MWCO. The
same filters were used to exchange the bu↵er from PBS to 10mM sodium phosphate (pH
7.4) for spectroscopy.
This protocol has been adapted and optimised in the Pinheiro laboratory by Timothy
Kaufmann and Rachel Smith, from various sources (Danzer et al., 2007; van Rooijen
et al., 2008; van Rooijen & van Leijenhorst-Groener, 2009; Fauvet et al., 2012; Sto¨ckl et al.,
2012a). The chromatogram shown in Figure 2.8 is highly reproducible, and the presence of
↵-synuclein oligomer was confirmed by immunoblot using the A11 confirmation detection
antibody (Lesne´ et al., 2006; Smith, 2013). Figure 2.10 was prepared by Rachel Smith
under my supervision, demonstrating the presence of A11-reactive oligomers prepared by
the methods described above. Di↵erent ↵-synuclein constructs were used, and A53T,
E46K:Y39W, and Y39W oligomers all show A11-reactivity. Oligomers prepared using
metal ions were not detectable here, just as ↵-synuclein monomer or bovine serum albumin
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Figure 2.8: Gel filtration size-exclusion chromatogram of ↵-synuclein post after oligomerisation
was carried out. The large peaks are residual monomeric protein that may be collected for later
use. The small peaks are oligomeric protein desired here.
were not detected.
In Chapter 1, the annular nature of amyloid oligomers was discussed, as this morphology
may be key to the ability of the oligomer to cause cell death. It was confirmed by Rachel
Smith and Timothy Kaufmann that the oligomers produced by this method are annular
(ring-shaped), and therefore of the same type as discussed in the literature. A scanning
electron micrograph taken of one such preparation is shown in Figure 2.9. The outer
diameter of the ring in this case was around 8 nm, and the inner was around 1 nm, though
the outer was found to be as big as 14 nm and the inner as big as 3 nm (Smith, 2013).
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Figure 2.9: Electron micrograph showing oligomeric E46K:Y39W. Inset shows single oligomer,
with inner diameter 1 nm, and outer diameter around 8 nm. Reproduced with permission of the
author (Smith, 2013).
Dot blotting was carried out by drying droplets of protein solutions on nitrocellulose
membrane (5 ⇥ 3µL), then incubating in blocking solution. This stage was followed by
incubating with the A11 antibody, then an anti-A11 secondary antibody. The membrane
was stained so the image could be captured.
Figure 2.10: Dot blot of ↵-synuclein size exclusion chromatography fractions gathered after
oligomer preparation. Blue colour indicates presence of A11-reactive species; the samples showing
positive for presence of oligomer were Y39W, Y39W incubated at reduced pH, E46K:Y39W,
E46K:Y39W at reduced pH, and A53T. In this case, metal ion presence during incubation,
monomeric ↵-synuclein, and BSA (control protein) all showed negative for oligomer presence.
Reproduced with permission of the author (Smith, 2013).
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The behaviour of lipid vesicles in
Couette flow
3.1 Introduction
Lipid vesicles have been used extensively in this work, as they are a convenient model
for the cell membrane. Much is still unknown, however, about the behaviour of vesicles
in di↵erent conditions, particularly in a shear flow system such as that of a Couette
flow linear dichroism experiment. Many studies concentrate on the behaviour of lipid
molecules, but often neglect the e↵ect of flow on the vesicle as a whole, whereas other
studies look at vesicles in flow but do not connect their modelling to experimental work
(Mader et al., 2006; Bagchi & Kalluri, 2009; Biben et al., 2011). In order to study the
alignment of lipid-interacting proteins using LD, the lipid systems used must be understood
and characterised. It must be known whether vesicles withstand Couette flow as the
orientation technique, and whether they align successfully. It must also be known whether
di↵erent lipids behave in the same way under flow, or whether lipid choice plays a role in
the success of these experiments. Theoretical work is reported in this chapter, describing
the relationship between vesicle shape, deformation of this shape, and orientation in flow.
Experimental work is also reported, showing how various types of lipid vesicle respond to
Couette flow, and how they leak their contents.
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A small molecule compound was used in the experiments described in this chapter: calcein.
Calcein, shown in Figure 3.1, is a very highly fluorescent, but also strongly self-quenching,
compound that was employed in measuring vesicle leakage, as in other studies of lipid
vesicle leakage when influenced by amyloid proteins (Sanghera & Pinheiro, 2002).
Figure 3.1: The structure of calcein, demonstrating several light-absorbing ring structures.
The data from this chapter contribute to the wider understanding that choices such as lipid
selection, made during experimental design, must be validated for their appropriateness
for downstream techniques.
3.2 Methods
3.2.1 Measuring calcein fluorescence
Calcein was sequentially diluted from 50mM by factors of two, and the fluorescence
measured at each concentration using a Jasco FP-6500 fluorimeter. Four measurements
were averaged for each spectrum, and the process was repeated in triplicate. The spectra
were plotted together, and the position of maximum fluorescence emission also recorded.
As calcein is at 50mM within the vesicles, fluorescence from within the vesicles may be
assumed to be zero; that is to say, any detected fluorescence may be assumed to be from
dye that has escaped the vesicles.
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3.2.2 Measuring vesicle leakage
Lipids were mixed to the required proportions, and prepared as described in Section 2.2.4,
40mg at a time. They were then resuspended in 2mL of bu↵er containing 0.1mM EDTA,
10mM TES, and 50mM calcein. Once thoroughly resuspended, the lipid was separated
into aliquots, and frozen at  20  C.
Vesicles formed from various mixtures of lipids were tested for their ability to withstand
Couette flow for extended periods of time, and for their ability to orient in such a system. It
was intended that optimal lipid compositions could be determined, and then recommended
for more detailed experiments. The lipids studied are given in Table 3.1. Vesicles used
were (molar fraction): 100% brain total lipid extract (BTLE); 100% soybean PC; 100%
DMPC, DPPC, or POPC; 75% DMPC or POPC, 15% cholesterol, 10% POPS.
Table 3.1: Lipids used in calcein-leakage and LD studies. The shorthand 16:0, 18:1, for example,
denotes a lipid containing one acyl chain 18 carbon atoms long with a single double bond, and one
16 carbon atoms long with no double bonds.
Lipid Acyl chain length and saturation Head group nature
DMPC 14:2, 14:2 Zwitterionic
DPPC 16:0, 16:0 Zwitterionic
POPC 16:0, 18:1 Zwitterionic
POPS 16:0, 18:1 Anionic
Cholesterol — Neutral
POPC/POPS/cholesterol 16:0, 18:1 Anionic, overall
DMPC/POPS/cholesterol 14:2, 14:2/16:0, 18:1 Anionic, overall
Soybean PC species 18:2, 18:2 (64%), various Zwitterionic
BTLE Various Various, mixed
charges and groups.
Lipids were thawed, then frozen and thawed twice, using dry ice and ethanol to achieve a
flash-freeze at around –78  C. Katherine Lloyd optimised this stage of the protocol within
the Rodger group (Lloyd, 2012). Suspensions of lipid were then extruded eleven times
using an Avanti mini-extruder, through a membrane with pore size 100 nm. A Nano-series
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Zetasizer (Malvern, UK) was used to measure dynamic light scattering (DLS) of the lipid
preparation to determine vesicle size. This was typically found to be a narrow distribution
around 100 nm. In some cases, vesicles were resuspended and then sonicated for 3minutes,
rather than being extruded, in order to compare the e↵ects of the di↵erent treatments on
leakage.
Columns of sepharose 4B were made using Pasteur pipettes by cutting excess length from
the tip and blocking with a small amount of cotton wool, before adding around 4 cm
of resin and allowing to settle. This was washed with sample bu↵er containing 0.1mM
EDTA, 10mM TES, and 100mM NaCl. 50µL of calcein-loaded, post-extrusion lipids were
purified through the column at a time by carefully depositing the vesicles onto the resin
bed and adding a drop of bu↵er. Finally, one column volume of bu↵er was added and
the vesicle-containing fraction collected manually. This was the second coloured band,
after the free dye had run though the resin. The resulting volume of size-separated vesicle
suspension was approximately 100µL.
A Bio-Logic MOS-450 spectrometer (Bio-Logic, Claix, France), was used to measure
leakage of the vesicle suspensions. Calcein fluoresces above 500 nm when excited by light
at 460 nm, so an in-line photodetector was fitted with a Hoya Y-50 long-pass wavelength
filter (Hoya, Santa Clara, CA, USA) preventing light below 480 nm reaching the detector.
A second photodetector, at 90 , had no filter, and therefore detected both fluorescence,
and scattered incident light.
The spectrometer was fitted with an LD cell (Dioptica Scientific, UK), able to generate
Couette flow for samples between 50 and 100µL. Using this apparatus, we were able to
observe the change in fluorescence over time with sample spinning at 3000 rpm, or without
spinning, or with intermittent spinning. A typical experiment measured fluorescence and
scattering over 30minutes.
After the final time point, Triton X-100 was added to a final concentration of 0.1% w/v.
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The concentration was such that 1µL could be added, minimising change in volume.
This detergent completely ruptured remaining vesicles, releasing all the calcein present,
giving a maximum possible fluorescence signal. This 100% reference was used to scale
measurements over the time course, and show how leakage changed over time. This step
provided a correction for the number of vesicles in the suspension (and therefore the
concentration of dye in the sample), as this can not be controlled at the size exclusion
stage. It was particularly noticeable that for pure DMPC a lower amount of dye (and
therefore of vesicles) had been eluted into the sample, so correcting for this e↵ect was
crucial.
3.2.3 Changes in geometry
The shape of a flow-distorted spherical vesicle (radius R) was approximated by adding
hemispheres to either end of a standard cylinder with radius r, and length h. The
hemispheres also have radius r. The domed-cylinder, or capsule, is shown in Figure 3.2.
r 
r 
r 
h
Figure 3.2: Schematic of capsule, or domed-cylinder, with cylinder length h, radius r, and total
length h+ 2r.
This capsule has volume
Vc =
4
3
⇡r3 + ⇡r2h, (3.1)
and surface area
SAc = 4⇡r
2 + 2⇡rh. (3.2)
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Surface area (SA) of the compressed vesicle capsule is understood to remain equal to SA
of the original sphere (de Haas et al., 1997), so
4⇡R2 = 4⇡r2 + 2⇡rh, (3.3)
which is solved for either h or r:
h =
2(R2   r2)
r
, (3.4)
and, by the quadratic formula,
r =
 h±ph2   16R2
4
. (3.5)
Two solutions for r were generated for each value of h, but only one was positive, and
therefore relevant to this work. By estimating a range of values for the length and radius
parameters, we obtained a value for the other, and then calculated how these values altered
the volume of the vesicle. This shows us how deformed the vesicle became under flow, and
how much of its contents were squeezed out.
3.2.4 Orientation in flow
The LD of the angle of an oriented vesicle relative to the direction of orientation is given
in Equation 3.6. This equation is essential to quantifying the relationship between vesicle
length, radius, and orientation.
LD = Aiso
3S
4
(1  3cos2 ), (3.6)
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Understanding the behaviour of theoretical vesicles in flow required computation of S from
Equation 3.6. The method of McLachlan et al., was implemented in MATLAB, in order
to compute S, for a range of lengths and radii of the capsule (McLachlan et al., 2013;
MATLAB, 2013).
3.3 Results and Discussion
3.3.1 Concentration-dependent fluorescence of calcein
As a self-quenching fluorophore, calcein emits fluorescence well at low concentrations,
and emits with very low intensity at high concentrations. Calcein has previously been
reported to emit its strongest fluorescence around 520 nm, with this figure being universally
accepted (Allen & Cleland, 1980). However, in this work it was noted that the maximum
wavelength of emitted fluorescence varies in a concentration-dependent manner, as well
as the intensity of emitted light varying as expected. Figure 3.3 shows emission spectra
for calcein excited at 460 nm, where the black line represents 50mM calcein, and dark
blue represents 0.19mM. As concentration decreased, intensity increased as expected.
Dilutions were made from 50mM until intensity began to decrease – 0.19mM – the point
where the dilution e↵ect overtook the e↵ect of elimination of quenching. The Figure also
demonstrates a shift e↵ect: as the concentration of calcein was reduced, the emission
spectrum undergoes a blue shift, revealing that maximum emission varies at least between
the 517 nm and 566 nm observed here.
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Figure 3.3: Emission spectra for calcein excited at 460 nm. Red spectrum represents emission
for the highest concentration, 50mM, green represents the median concentration, 3.13mM, and
blue represents the lowest concentration tested, 0.19mM.
Figure 3.4 shows the wavelength of maximum emission ( max) plotted against calcein
concentration, and fitted by:
 max = 9.336ln[calcein] + 530.11, (3.7)
which provided a means to estimate calcein concentration from fluorescence data.
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Figure 3.4: Concentration of calcein versus  max of emitted fluorescence. Green circles are
measured values with error bars indicating one standard deviation from the mean after 3 replicates
(in some cases 0), dashed line is the curve fitted to the data:  max = 9.336ln[calcein]+530.11. The
R2 value for this fit is 0.99021.
A key aspect of the success in gathering these data is the sensitivity of the instrument
used, requiring the pre-selection of excitation and emission bandwidths. In this work,
fluorescence intensity has been used to measure calcein leakage. However, these data open
up potentially better options and opportunities for di↵erent experimental design. These
data are a proof of principle that using  max as a dependent variable would be e↵ective,
and enable more precise concentration measurements by interpolation.
3.3.2 Calcein leakage measurements to measure vesicle stability
the vesicle preparation method was tested by DLS for reproducibility of vesicle size. DLS
data gathered from the lipid samples is shown in Figure 3.5. The Figure demonstrates
70
CHAPTER 3. VESICLE BEHAVIOUR
that most vesicle types are measured to be around 100 nm diameter after extrusion, though
some are bigger before extrusion. In one case a sample was measured after Couette flow
(DMPC), and was found to measure around 615 nm, demonstrating the damaging e↵ect
of Couette flow on DMPC vesicles.
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Figure 3.5: DLS gathered for (top) vesicles pre-extrusion post-Couette flow, and (bottom)
vesicles post-extrusion. In DLS, larger particles scatter more light, meaning the higher peaks may
represent fewer particles.
Vesicles were prepared containing 50mM calcein. As demonstrated by the data in Section
3.3.1, calcein at this concentration has negligible fluorescence. After extrusion to 100 nm
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diameter, vesicles were purified by size-exclusion chromatography to exclude free dye.
In some cases, the extrusion step was swapped for sonication – another lipid preparation
method used by some research groups – in order to compare leakage from vesicles prepared
by both methods. Vesicles were then loaded into a Couette cell, and fluorescence measured
for 30minutes, with or without rotation at 3000 rpm. Detergent was then added, and the
vesicles disrupted. Once all the calcein had been released from the vesicles, a value for
100% fluorescence was obtained, and used to scale the leakage data. Figure 3.6 shows
these collated traces.
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Figure 3.6: Fluorescence of calcein leaked from vesicles: (a & c) stationary, and (b & d) in
Couette flow at 3000 rpm. (a & b) show traces for pure DMPC, DPPC, POPC and soybean PC.
(c & d) show traces for POPC/POPS/ cholesterol, DMPC/POPS/ cholesterol, BTLE. Label “E”
indicates extruded lipids, “S” indicates sonicated. Fluorescence was recorded for 1800 seconds,
then detergent added to lyse all vesicles, and release 100% of encapsulated calcein. The resulting
fluorescence value was considered 100%, and all other values described as a percentage of this value,
thereby correcting for di↵erences in concentration. Traces for pure DMPC vesicles are shown as
dashed lines, indicting values that have been fitted to a curve, since measured values had poor
signal:noise.
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Signal:noise was so low for pure DMPC data, that these traces were fitted to standard
curves, as shown in Figure 3.7.
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Figure 3.7: Data gathered for calcein leakage from our DMPC vesicles. Blue stars are collected
data without Couette flow, red circles for leakage with couette flow. The green line is the
curve fluorescence = 70e( 0.02time) fitted to the Couette flow data, the orange line is the curve
fluorescence = 70e( 0.004time) fitted to the data without Couette flow.
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Taken together, Figures 3.6 and 3.7 demonstrated that certain vesicles cope badly with
conditions of Couette flow at 3000 rpm, and some vesicles were extremely leaky even
without flow applied. Pure DMPC leaked most of its contents by 500 seconds, whether
or not flow was applied. Leakage was exacerbated by Couette flow, however, stabilising
at around 100 seconds. DPPC performed similarly to DMPC in flow, though was slightly
more resilient over time when flow was not applied. As pure lipids, therefore, these vesicle
preparations might be considered too weak to endure an LD experiment.
Pure POPC, on the other hand, or the mixed soybean PC, both endured the leakage assay
well, with around 5% leakage after 30minutes. When produced from other heterogeneous
mixtures (POPC or DMPC with POPS, or BTLE), the vesicles also survived better than
for pure DMPC or DPPC. The shorter acyl chains of DMPC and DPPC did seem to reduce
vesicle stability when present, compared to POPC, but not so dramatically as when the
sole vesicle component. Soybean PC and BTLE were both extremely stable over the whole
course of the experiment.
Interpretation of these results required further context; it was necessary to understand
more deeply the relationship between calcein leakage and vesicle orientation in flow. It
may be necessary to study the possibility that the calcein solution is not stable within the
vesicle. Should calcein leak without its solvent (aqueous bu↵er), or should the bu↵er leak
while calcein remains in the vesicles, the internal and external concentrations of calcein
would be altered, and our assumptions a↵ected. This could be studied by fluorescence
detected linear dichroism, for example, monitoring whether the calcein had partitioned
into the lipid membrane.
As noted in Section 3.3.1, if  max can be measured, following the addition of detergent to
cause 100% dye release, it would be possible to calculate calcein concentration using
Equation 3.7. From a typical POPC vesicle sample, a free calcein concentration of
0.403mM was obtained. Here, this result implies that vesicle contents accounted for
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around 1% of the sample volume (since the vesicles initially contain 50mM calcein). This
result demonstrates that using the  max method is a useful way to assess the quality of
vesicle preparation techniques.
3.3.3 Vesicle Geometry
It was possible to model the e↵ect of flow on the orientation and geometry of vesicles. It
was known from previous data that feasible values for the orientation parameter S are
around 0.03, i.e. a value of S of 0.03 would be suitable orientation for the corresponding
LD experiment to generate good signal (Rodger et al., 2002; Norde´n et al., 2010). This
does not imply that S = 0.03 is a prerequisite to generating LD data, but gives the
value around which one would expect a particle generating LD signal to have achieved
under flow. Previous work in the Rodger group had also generated an analytical method
for calculating S for rigid particles, based on a velocity of flow, and on the length and
diameter of particles in that flow.
A set of parameter values for the length and radius of a capsule with the same surface area
as a sphere with diameter 100 nm was derived. A sample of these values, and the resulting
value of S, calculated by the McLachlan et al. method, is shown in Table 3.2 (McLachlan
et al., 2013). The full data are plotted in Figure 3.8, with S = 0.03 indicated on the plots.
It may be noted that there is an asymptote to both these plots and we are working in the
vicinity of this asymptote. It may be the case that this model does not capture the full
experimental range, and could need reformulation in light of later data.
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Table 3.2: Calculated values for vesicle volume (V ) and the orientation parameter, S, for
di↵erent values of r and h.
r / nm h / nm V / nm3 S
5.00 990.00 78278.0 0.5882
10.00 480.00 154985.2 0.3391
15.00 303.33 228550.9 0.1757
18.10 240.00 271929.0 0.1122
19.33 220 .00 288512.5 0.0939
20.71 200.00 306717.1 0.0771
26.00 140.31 371596.0 0.0396
26.03 140.00 371971.4 0.0394
27.13 130.00 384382.4 0.0351
28.00 122.57 393846.8 0.0322
28.31 120.00 397167.1 0.0313
30.00 106.67 414690.2 0.0270
37.20 60.00 499628.2 0.0178
38.00 55.58 481979.0 0.0173
40.00 45.00 494277.2 0.0165
40.99 40.00 476529.9 0.0162
45.00 21.11 516006.6 0.0159
45.25 20.00 516733.2 0.0159
When the length and radius of the vesicle is altered, the volume is altered, as any parameter
combination has less volume than the original sphere. As shown in Table 3.2, when
S ⇡ 0.03, V ⇡ 397000 nm3, i.e. around 75% the volume of a spherical vesicle with radius
50 nm. Therefore, to achieve S = 0.03 a vesicle must lose 25% of its contents as its shape
is altered by Couette flow.
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Figure 3.8: Plots demonstrating the e↵ect of changes in h and r on S for compressed vesicles
in flow. Surface area was fixed, and volume allowed to change. Dotted line is at S = 0.03, an
experimental value for vesicle orientation (Norde´n et al., 1992; Rodger et al., 2002; Norde´n et al.,
2010).
3.4 Conclusions
Here, it has been shown that vesicles of di↵erent compositions behave very di↵erently in
Couette flow. This has serious implications for any LD experiment that might seek to
use Couette flow and lipids. Couette flow is currently the best choice for orientation of
lipids, so the impact of this flow on the lipid must be taken into account. Any investigator
attempting LD with vesicles must consider these results, and at least compare their lipid
selection to those used here. It has been shown that vesicles must undergo significant
deformation to orient in Couette flow, but must also be stable enough to maintain their
integrity at the same time.
A previously experimentally verified value for the orientation parameter S in a lipid LD
experiment is 0.03. It was anticipated that if vesicles would give good LD signal, their
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orientation S would be approximately 0.03. According to the data presented here, a vesicle
is required to expel 25% of its contents in order to conform to this degree of alignment.
Some of the lipid systems examined in these experiments leak much more than 25% of
their contents; pure DMPC and DPPC, specifically. These lipids, therefore, are not able
to merely align in the flow, but are deformed to a much greater degree, and risk being
ruptured completely in a long experiment. The vesicles are extremely porous even without
the e↵ect of Couette flow, suggesting that as cell membrane models they are unsuitable
anyway.
Some vesicle compositions examined here leak much less than 25% of their calcein contents:
BTLE and soybean PC, for example, lose around 5% with or without Couette flow. This
may imply they are unsuitable for LD as they do not deform enough to behave as capsules
in flow. They may never orient well enough to give S = 0.03, however it would be necessary
to establish the quality of any resultant LD of using these vesicles. As later work shows,
the work in this chapter informs lipid choices for LD but is not definitive – successful LD
may be gathered when using BTLE. More work may be needed to understand the full
range of processes occurring.
Finally, two types of vesicle leaked calcein at a rate broadly comparable to the calculated
25%: POPC/POPS/cholesterol, and DMPC/POPS/cholesterol. These mixtures have
some degree of complexity compared to pure lipid preparations, enabling more experiments,
and both appear fluid enough to compress under flow, but not likely to rupture completely
in these conditions. These data suggest that these lipids are good candidates for LD.
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Fluorescence spectroscopy study
of ↵-synuclein lipid binding
4.1 Introduction
Wild type ↵-synuclein contains four tyrosine residues at positions 4, 39, 94, and 125.
Tyrosine is fluorescent, but not strongly so, especially once incorporated into protein.
Additionally, the presence of multiple residues per molecule would make conclusions
about lipid interaction extremely di cult to draw. This was resolved by introducing
a single tryptophan residue in place of one of the tyrosines. Tryptophan is known to
emit fluorescence around 352 nm when excited at 295 nm in aqueous solution. When in
hydrophobic environments the emission wavelength shifts to lower wavelengths. Y4W and
Y94W mutant forms of ↵-synuclein show this shift strongly, Y39W clearly but less so, and
Y125W to a negligible extent (Pfe↵erkorn & Lee, 2010). The most relevant tryptophan
substitution for this work was Y39W, since this puts the tryptophan residue closest to
the disease-associated mutations at positions 30, 46, 50, 51, and 53 (Conway et al., 1998;
Warner & Schapira, 2003; Zhu et al., 2003; Choi et al., 2004; Zarranz et al., 2004; Appel-
Cresswell et al., 2013; Fares et al., 2014).
In this chapter, Y39W ↵-synuclein was mixed with lipid vesicles of various types, and the
fluorescence of the tryptophan residue measured. A second protein construct containing
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the E46K disease-associated mutation as well as Y39W was also used in these experiments,
allowing for a comparison in lipid interaction at residue 39 for the Parkinson’s Disease-
linked case, and the non-disease case. The lipids used were selected for biological relevance
and prevalence in neurones. They were: POPC, POPS, cholesterol, sphingomyelin (SM1),
and the ganglioside GM1.
4.2 Materials and Methods
Table 4.1 shows the range of vesicle compositions used to study the ability of ↵-synuclein
to bind lipid bilayers in the form of vesicles. These mixtures were chosen to observe
the binding between ↵-synuclein and physiologically relevant, negatively charged, POPS,
and then to determine the e↵ect of cholesterol, and SM1 on these interactions. Several
specific interactions have been proposed between gangliosides and ↵-synuclein (as well as
other amyloid proteins), so GM1 was included in our lipid selection (Martinez et al., 2007;
Sanghera et al., 2011). Vesicles were prepared by the sonication method as described in
Section 2.2.3.
Table 4.1: Lipid mixtures used in monomer-lipid binding studies.
% POPC % POPS %Cholesterol %Sphingomyelin %GM1
100 0 0 0 0
90 10 0 0 0
75 25 0 0 0
50 50 0 0 0
75 10 15 0 0
65 10 15 10 0
60 10 15 10 5
Experimental samples were prepared as mixtures of protein and lipid at di↵erent molar
ratios. In each sample, ↵-synuclein solution and lipid suspension were mixed in equal
volumes, diluting both by a factor of two. After this dilution, protein was at 10µM
(approximately 0.1mg/mL). Lipid concentrations were such that a range of molar ratios
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from 1mole protein : 1mole lipid, up to 1mole protein : 1000moles lipid were made.
The ratios were: 1:1, 1:5, 1:7.5, 1:10, 1:25, 1:50, 1:75, 1:100, 1:250, 1:500, 1:750, and
1:1000 moles. Fluorescence spectra were measured as described in Section 2.2.2, taking
care to measure and subtract the appropriate backgrounds for each sample – i.e. lipid
diluted to the same concentration as in the sample, but protein solution replaced by
bu↵er only. These were measured in the same experimental session, reducing the chance
of environmental di↵erences a↵ecting the result.
From each spectrum, the wavelength of maximum intensity of emitted light was obtained,
and plotted as a function of lipid concentration. Default fitting algorithms within the data
analysis packages Prism R  and Sigmaplot R  were used to fit one-site ligand-binding curves
to the data and extract apparent dissociation constants (Prism, 2015; SigmaPlot, 2013).
The method used in this fitting is shown in Appendix B.
4.3 Results and Discussion
4.3.1 Lipid-binding is marked by shift in fluorescence spectra
Tryptophan is hydrophobic and polar, and therefore is often an amino acid involved in
interactions with hydrophobic environments, such as a lipid bilayer. Intrinsic tryptophan
fluorescence experiments were designed to assess the strength of the interaction between ↵-
synuclein and lipids, by monitoring the characteristic emission wavelength of this residue.
The two constructs of ↵-synuclein were mixed with vesicles prepared from di↵erent mixtures
of lipids, then fluorescence spectra measured.
POPC was chosen as the predominant, zwitterionic, lipid in our vesicle preparations, with
POPS as the anionic component. We studied a range of ratios of these lipids from 100%
POPC to 50% POPC. Neither of the protein constructs (Y39W and E46K:Y39W) would
be expected to bind strongly to POPC, based on previous data (Davidson et al., 1998;
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Eliezer et al., 2001; Bussell & Eliezer, 2003; Choi et al., 2004). Indeed, with no POPS
present we observe very little interaction. With anionic lipid present, it was expected that
pronounced shifts in protein structure would be observed. Figure 4.1 demonstrates the
changes observed in fluorescence spectra for Y39W, and Figure 4.2 shows equivalent data
gathered for the E46K:Y39W protein.
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When no POPS was present, most of the samples showed hardly any deviation from protein
in solution (solid black line). We observed shifts in the fluorescence for samples containing
10, 25, and 50% POPS. These shifts a↵ect the wavelength at which maximum emission
is detected ( max): as the tryptophan residue moves from an aqueous to a hydrophobic
environment it emits fluoresced light at a lower wavelength. This is known as blue shift.
We may deduce that if the blue shift is larger, a greater proportion of Trp residues are
inserted into the membrane: a measure of the strength of the binding.
The spectrum appeared to shift for ratios higher than 1:100 moles in the 10% and 25%
POPS cases. The shift was apparent from around 1:50 moles in the 50% POPS cases,
demonstrating that higher proportions of PS present greater binding opportunity for the
protein.
When the blue shift was plotted as a function of lipid concentration, binding curves are
produced. These are shown in Figure 4.3. The apparent dissociation constants derived
from these plots (KDapp) are shown in Table 4.2.
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Figure 4.3: Blue shift plotted as a function of lipid concentration for (top) Y39W and (bottom)
E46K:Y39W. Points shown indicate measurements of blue shift for vesicles of 100% POPC (circles),
10% POPS (squares), 25% POPS (filled triangles), and 50% POPS (downward triangles). Each
data point is the average of three measurements, with error bars showing one standard deviation
from the mean. Approximate binding curves were fitted using Prism one-site ligand binding
algorithms, fitting equation y = Bmaxx/(Kd + x). Examples of the method used by Prism are
shown in Appendix B.
A fluorescence-negative control was carried out usingWT ↵-synuclein. Since no tryptophan
residues are present, excitation at 295 nm does not give rise to meaningful fluorescence
signals, and only negligible signals are observed. This experiment was carried out using
POPC/POPS vesicles, with a molar ratio of 1:1. The data are shown in Figure 4.4.
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Figure 4.4: Fluorescence spectra for WT ↵-synuclein mixed with POPC/POPS vesicles. Both
lipids were at 50% mole/mole. Samples excited at 295 nm. Due to the di↵erent relative units used
by this Jasco fluorimeter, values are smaller by a factor of approximately 500 than they would
appear if measured on the PTI fluorimeter used for most of the previous measurements. Spectra
have not been normalised for concentration.
Figure 4.4 demonstrates that fluorescence signals observed above (Figure 4.1 and Figure
4.2) were entirely due to the presence of the tryptophan residue, justifying its use. The
interaction between ↵-synuclein and negatively-charged POPS, however, is not believed
to be specific, and may not explain the role of the protein in disease. In the literature,
for example, binding has been demonstrated using similarly charged PG lipids (Rhoades
et al., 2006; Ferreon et al., 2009). It was necessary to attempt to approximate more
closely the complexity of native, neuronal membranes, and attempt to discern a specific
interaction.
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4.3.2 Influence on binding of increased complexity of membranes
Several other lipids play important biological roles in membranes, and some of these were
incorporated one at a time in order to deduce which, if any, had the biggest impact on ↵-
synuclein lipid-binding. First, cholesterol: a key lipid for membrane fluidity and stability
properties was added. Sphingomyelin (SM1), implicated in signalling pathways, apoptotic
pathways, and lipid raft formation (Kolesnick & Golde, 1994), was incorporated. The final
lipid to be added to the preparation was the ganglioside GM1, as it has roles in binding
events in various systems.
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Figure 4.5: Fluorescence spectra gathered for Y39W, and E46K:Y39W alpha-synucleins, mixed
with POPC/POPS/cholesterol vesicles. Vesicle composition is 15% cholesterol, 10% POPS, 75%
POPC. Spectra have not been normalised for concentration.
Upon addition of 15% cholesterol, both proteins once more display the same range of shift
in  max from 352 to 340 nm, and both display any shift only once a protein:lipid molar
ratio of 1:100 has been passed. This implies that cholesterol does not a↵ect lipid binding.
This is in accord with the hypothesis that it is the charged POPS lipid that facilitates the
binding process. This result is not surprising, but has not been shown before now.
SM1 was also added to the vesicle preparation. The wide range of reported functions for
SM1, especially the role it has in putative lipid rafts, made it a potential binding target for
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specific amyloid interactions (Kolesnick & Golde, 1994). These data are shown in Figure
4.6.
300 350 400 450
0
50000
100000
150000
200000
Wavelength / nm
In
te
ns
ity
 (a
rb
itr
ar
y 
un
its
)
Fluorescence spectra, Y39W, PC/PS/Cholesterol/SM1 SUVs
protein only
1:1
1:5
1:7.5
1:10
1:25
1:50
1:75
1:100
1:250
1:500
1:750
1:1000
300 350 400 450
0
50000
100000
150000
Wavelength / nm
In
te
ns
ity
 (a
rb
itr
ar
y 
un
its
)
Fluorescence spectra, E46K:Y39W, PC/PS/Cholesterol/SM1 SUVs
protein only
1:1
1:5
1:7.5
1:10
1:25
1:50
1:75
1:100
1:250
1:500
1:750
1:1000
Figure 4.6: Fluorescence spectra gathered for Y39W, and E46K:Y39W alpha-synucleins, mixed
with phospholipid vesicles. Vesicle composition is: 10% SM1, 15% cholesterol, 10% POPS, 65%
POPC. Spectra have not been normalised for concentration.
The addition of SM1 also seemed not to a↵ect the position of  max, or the molar ratio
at which blue shift becomes observable, again indicating that any binding in this system
is dominated by POPS. No evidence was found in these data that SM1 has enhanced or
reduced the binding a nity of the protein for lipids.
Finally, GM1 was incorporated into vesicles, and the experiment repeated. Amyloid-
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Figure 4.7: Fluorescence spectra gathered for Y39W, and E46K:Y39W alpha-synucleins, mixed
with phospholipid vesicles. Vesicle composition is: 5% GM1, 10% SM1, 15% cholesterol, 10%
POPS, 60% POPC. Spectra have not been normalised for concentration.
ganglioside interactions had been demonstrated previously; an increase in binding ability
would have validated these hypotheses further. These spectra are shown in Figure 4.7.
Once again, however, the spectra strongly resemble those for POPC/POPS vesicles, at
10% PS. The data shown here do not suggest that Y39W or E46K:Y39W ↵-synuclein
interact specifically with GM1, only with POPS. Binding curves for these data, generated
as above, are shown in Figure 4.8. When compared to Figure 4.3 it is apparent that the
curves are shifted to the right, i.e. more lipid is needed to give a binding e↵ect. This
became clearer when binding coe cients were compared between Table 4.2 and Table
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Figure 4.8: Blue shift plotted as a function of lipid concentration for Y39W and E46K:Y39W
mixed with lipid vesicles of 3, 4, and 5 component lipids. All vesicles contained 10% POPS and 15%
cholesterol. 4 component vesicles also contained 10% SM1, 5 component vesicles also contained
5% GM1. the remainder was POPC in each case. Diamonds, triangles, and blue circles represent
data points for Y39W protein, squares, downward triangles, and black circles represent points
for E46K:Y39W. Circles are for 5 component vesicles, triangles for 4 component, and squares
for 3 component. Approximate binding curves were fitted using Prism one-site ligand binding
algorithms, fitting equation y = Bmaxx/(Kd + x). Examples of the method used by Prism are
shown in Appendix B.
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Table 4.2 shows the values for KDapp for ↵-synuclein binding to small unilamellar vesicles
of POPC/POPS in various ratios. These were calculated using a ligand binding algorithm
in the SigmaPlot package. These values for KDapp demonstrate the increase in a nity
of protein for membrane when more POPS is present. There is an order of magnitude
improvement between the 10% case and the 25% case. The increase in a nity is smaller
between the 25% and 50% cases. However, di↵erences between KD for the two protein
constructs are much less pronounced. More data would be required to make conclusions
about whether these are truly significant KD di↵erences, but it appears that both the
Y39W and the E46K:Y39W interact with these lipids with similar a nity.
Table 4.2: KDapp calculated within Prism for two ↵-synuclein constructs, binding to SUVs
containing various percentages of POPC and POPS. These figures were calculated using a simple
one-site ligand binding algorithm within Prism. Errors given represent the standard error, also
calculated within Prism.
KDapp / µM
% POPS Y39W E46K:Y39W
0 — —
10 259.9 ± 18.9 398 ± 23.0
25 82.0 ± 12.4 76 ± 5.5
50 34.4 ± 7.6 41 ± 1.4
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Table 4.2, showing KDapp for POPC/POPS vesicles, may be compared to Table 4.3,
showing KDapp for complex vesicles. The values in Table 4.3, coupled with the curves
shown in Figure 4.8 suggest that increasing the complexity of the membranes dramatically
reduced the a nity of the protein for the membranes. While some of the values are
spurious given that our molar ratios only went up to 1:1000 moles (8538, for example), it
is clear that these values are much higher than those in Table 4.2, allowing the conclusion
that ↵-synuclein would bind less readily to complex membranes, and more readily to simple
membranes containing large amounts of POPS. This may be due to compartmentalisation
of membranes into domains such as lipid rafts - this would, in e↵ect, reduce the number
of binding sites, although the sites would be larger.
Table 4.3: KDapp calculated within Prism for two ↵-synuclein constructs, binding to SUVs
containing 10% POPS and 15% cholesterol. The latter two contained 10% SM1, the final data
are for SUVs containing 5% GM1. The remainder of the lipid is made up of POPC. These figures
were calculated using a simple one-site ligand binding algorithm. Errors given represent standard
error from the mean, also calculated within Prism.
KDapp / µM
Component addedd Y39W E46K:Y39W
Cholesterol (15%) 781 ± 146 591 ± 107
Cholesterol and SM1 (10%) 1518 ± 674 2703 ± 1860
Cholesterol, SM1, GM1 (5%) 1654 ± 627 8358 ± 12466
This result has implications for experimental design in that if a strong binding e↵ect is
required, it may actually be detrimental to use realistic membrane complexity. However,
this may at least partly explain why Parkinson’s Disease takes so long to develop, as the
protein-lipid interaction could be extremely ine cient in vivo.
4.3.3 Determination of the ability of GM1 to interact with ↵-synuclein
in the absence of POPS
Since GM1 is known to interact with amyloid proteins (Fantini & Yahi, 2011; Sanghera
et al., 2011), a final fluorescence experiment was carried out with only POPC and GM1
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present in the vesicle preparation. This was to determine if the proteins used here were able
to interact with GM1 at all. The spectra are shown in Figure 4.9, and do not demonstrate
any blue shift. It was concluded that constructs of ↵-synuclein that contain the Y39W
mutation are not able interact with GM1. This result contradicts earlier data, specifically
that gathered by Fantini and Yahi (Fantini & Yahi, 2011). However, their data do suggest
that the tyrosine at position 39 is critical for the interaction with GM1. Although Trp
and Tyr are often suggested as functionally interchangeable, due to their similar size and
hydrophobicity, it appears that the hydroxyl group on the Tyr residue may be key to this
GM1 binding. The Trp mutant used here cannot replicate the e↵ect.
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Figure 4.9: Fluorescence spectra gathered for E46K:Y39W alpha-synuclein, mixed with
phospholipid vesicles. Vesicle composition is: 5% GM1, 95% POPC. Spectra have not been
normalised for concentration.
4.4 Conclusions
In this chapter the intrinsic fluorescence of tryptophan has been used to make inferences
about how ↵-synuclein interacts with lipid membranes. The shift in the characteristic
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fluorescence spectrum of the residue reveals how readily the indole ring structure inserts
into the membrane, away from its aqueous environment. It has been demonstrated that
although this process occurs reliably when POPS is present in the lipid mixture, other
lipids tested have no influence on this interaction. POPC, cholesterol, SM1, and GM1
have not exhibited any propensity to increase the strength of binding, or at what level of
protein:lipid molar ratio it occurs.
Attention has been drawn to the work of other investigators, showing that ↵-synuclein does
have specific interaction with GM1, and evidence has been presented that using Y39W
variants of the protein may have eliminated this interaction. Further reference to this
conclusion is drawn in other chapters of this work.
In Chapter 5, the samples discussed here were used again for circular dichroism experiments.
This enables the context of tryptophan membrane insertion to be understood, and a
relationship between that process and other measures of binding to be explained.
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Circular dichroism spectroscopy
studies of protein-lipid
interaction
5.1 Introduction
To further answer the question of how ↵-synuclein interacts with lipid membranes, three
sets of experiments were carried out. First, using the same samples used in Chapter 4, the
CD spectrum of ↵-synuclein was measured for di↵erent molar ratios of protein to lipid.
Comparisons were made for Y39W and E46K:Y39W ↵-synuclein, and for lipid systems
containing increasingly complex mixtures of lipids. Any di↵erences in binding between
the two constructs can be compared, and also compared to the fluorescence data from
Chapter 4.
Second, it was desirable to use a model protein so that as much comparable data as
possible was obtained. Melittin was selected. This protein has been studied by the Rodger
group, and other groups, as its lipid insertion is an interesting case study of a relatively
short peptide, with strong, observable, structural changes (Sui et al., 1994; Damianoglou
et al., 2010; Svensson et al., 2011). The structure of the melittin dimer (adopted in
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lipidic environments) is shown in Figure 1.14 (Terwilliger & Eisenberg, 1982a,b; Pettersen
et al., 2004). The experiments presented here give further data on how melittin interacts
with lipid membranes, and also provide good context for the lipid binding of ↵-synuclein.
They were carried out in a linear dichroism LD cell, also providing validation of this as
a development of CD instrumentation. Good CD data in these sub-optimal conditions
represents useful progress for those with very small volumes of sample, for example.
Utilising the LD cell for CD requires smaller sample volumes than in a conventional CD
cell, and also minimises the risk of sample loss during cuvette exchange. CD and LD
provide complementary data (secondary structure and orientation), so an experimentalist
should seek to gather both spectra during a session. It may be the case that one would
wish to measure CD before and after the flow of LD, so the process again saves time and
sample loss during the exchange. The ability to gather two distinct sets of data, reliably,
without needing to even open the cover of the instrument would improve e ciency, and
uptake of the LD cell.
Finally, CD measurements were made of ↵-synuclein monomer and oligomer in the LD
cell. With all the context from the previous CD data, these results can be discussed with
confidence, and provide interesting points on how monomeric, and oligomeric, protein
appears to adapt to the lipid environment. The oligomeric form of the protein has
been characterised in the Pinheiro laboratory by Rachel Smith and Timothy Kaufamnn,
and found to be annular and A11 antibody-positive (Smith, 2013). These structures,
approximately 10 nm in diameter, would form small pores in the cell membrane on insertion,
with their aperture being between 1 and 3 nm wide, so determining whether insertion does
or does not occur may go some way to solving the method of toxicity.
A small molecule compound was used in the experiments described in this chapter: 1,6-
diphenyl-1,3,5-hexatriene (DPH). As Figure 5.1 shows, DPH is a linear, light-absorbing,
fluorescent, hydrophobic, compound, that inserts into lipid films (Prendergast, 1978;
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Kaiser & London, 1998; Carafa et al., 1998). It was incorporated at this stage, though
its main use would be when the vesicles used here were later used for linear dichroism
experiments.
Figure 5.1: Structure of 1,6-Diphenyl-1,3,5-hexatriene, demonstrating hydrophobic acyl chain.
5.2 Methods
Monomeric protein lipid-binding experiments were carried out using the method described
in Section 2.2.2. Spectra were measured for protein:lipid ratios of 1:1 moles, up to 1:1000
moles, with ↵-synuclein at 10µM. Table 4.1 shows the range of vesicle compositions that
were studied in this experiment. Lipids were prepared by the sonication method described
in Section 2.2.3, and mixed with protein shortly before use. The same samples were
used for fluorescence and CD measurements. CD signal at 222 and 208 nm was used for
calculation of binding curves as for the fluorescence data shown in Chapter 4.
For melittin and the later ↵-synuclein CD experiments, the parameters were changed
substantially. Lipids were prepared by the extrusion method described in Section 3.2.2.
The resuspension bu↵er was 10mM sodium phosphate, pH 7.4. Data were gathered in
Jasco J-1500 and J-815 spectropolarimeters, and all data were collected for 80–100µL of
sample in a 0.5mm path length capillary, stationary in an LD cell. Measurement speed
was 200 nm/min, integration time was 0.5 seconds, and each spectrum was the average of
8 measurements. Data were gathered from 180 nm to 500 nm in order to gain as much
information on the quality of the measurement system as possible, though the protein
region between 190 and 260 nm was particularly relevant.
Both melittin and ↵-synuclein were mixed to a molar ratio of 1:100 (protein:lipid), with
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protein at 0.1mg/mL: approximately 35µM for melittin and 10µM for ↵-synuclein. Monomeric
and oligomeric forms of ↵-synuclein were used, the oligomeric form prepared as described in
Section 2.2.6. Lipid vesicles used contained 1% w/w diphenylhexatriene (DPH), and four
di↵erent mixtures of lipids: Brain total lipid extract, soybean PC, POPC/POPS/cholesterol
(molar ratio 75:10:15), and DMPC/POPS/cholesterol (molar ratio 75:10:15). Lipids were
prepared by the extrusion method described in Section 2.2.4, and mixed with protein
shortly before use. These samples were also used for linear dichroism measurements.
5.3 Results and Discussion
5.3.1 The secondary structure of ↵-synuclein on interaction with lipids
Circular dichroism spectra were gathered using the same samples as in fluorescence experiments,
with minimal time between measurements. In this case, the change in secondary structure
of the protein was the result of interest, demonstrated by the presence or absence of bands
at 200, 208, and 222 nm for ↵-helix, or 200 nm for disordered protein.
Representative spectra for Y39W are shown in Figure 5.2. No folding was demonstrated
in the 100% POPC case until very high lipid:protein ratios: the band at 200 nm was
unchanged until 1:500 moles was reached, and even in that case the protein is intermediately
folded at best, with only a small shift from the other spectra shown. With higher
proportions of POPS, the change from disordered protein to folded protein is strongly
evident, with bands at 222 and 208 nm reaching larger magnitudes than the 200 nm random
coil band.
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A control experiment was carried out using wild type (WT) ↵-synuclein and 50% POPC/POPS
vesicles in order to confirm that the Y39W mutation does not a↵ect interaction of the
protein with POPS. These data are shown in Figure 5.3. While these data are noisy,
the change from unstructured protein to ↵-helix evidently occurs at near to the same
protein:lipid ratios as in the Y39W case. The fact that the 1:75 moles spectrum in figure
5.3 appears to be random coil may suggest that WT protein (Y39) does not interact quite
to readily with the lipid as Y39W.
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Figure 5.3: CD spectra gathered for WT ↵-synuclein mixed with vesicles containing 50% POPS,
50% POPC. Cuvette path length was 1mm, and protein concentration was 10µM.
The random coil spectra shown in Figure 5.3 have approximately the same magnitude
as for E46K:Y39W ↵-synuclein, so the trend from random coil to ↵-helix is judged to
be correct. The low signal:noise ratio is presumed to be due to the bu↵er in which the
WT protein was supplied in a bu↵er containing various components known to generate
artefacts on CD spectra (NaCl, MgCl2, Tris-HCl). while these were diluted many times
from the original stock, it may be the case that they interfered with the spectra.
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Representative spectra for E46K:Y39W ↵-synuclein are shown in in Figure 5.4.
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Again, little di↵erence was observed when no POPS was present. The band at 200 nm is
pronounced, and is the only strong signal visible. In samples where the lipid contains 10,
25, or 50% POPS, the di↵erences are striking, with the 200 nm band diminishing at ratios
above 1:10 moles of protein to moles of lipid. When ratios above 1:500 moles are used, the
spectra have no band at 200 nm, and very strong bands at 208 and 222 nm: the protein is
clearly ↵-helical. The band at 200 nm is concealed by scattering due to the nature of lipid
vesicles in suspension.
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With greater proportions of POPS present, the shift to ↵-helix may occur at lower ratios
of protein to lipid. In the previous chapter, binding curves were generated by plotting
lipid:protein ratio against blue shift of the fluorescence spectra. A similar technique is
possible in the CD case, by plotting the lipid:protein ratio against the change in CD
signal for the key ↵-helix band wavelengths at 222 nm and 208 nm. Figure 5.5 shows these
fitted curves.
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Figure 5.5: Fitted curves for shift in CD spectra at 222 nm and 208 nm plotted against
lipid:protein ratio for Y39W ↵-synuclein (top) and E46K:Y39W (bottom). Blue, green, yellow,
and brown data series represent 222 nm, red, purple, black, and dark blue represent 208 nm. data
is scaled by percentage of CD signal, where minimum is the signal at 0 lipid, and maximum is that
achieved for 50% POPS. Apparent binding curves were fitted using Prism one-site ligand binding
algorithms, fitting equation y = Bmaxx/(Kd + x).
Figure 5.5 demonstrates that CD signal changes in a concentration dependent manner as
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the protein interacts with the lipid, i.e. the folding of the protein does not take place all
at once. From these fits, dissociation constants may be derived, and therefore compared
to those gathered from fluorescence data explained in Chapter 4. Table 5.1 shows these
calculated values.
Table 5.1: KDapp calculated within Prism for two ↵-synuclein constructs, binding to SUVs
containing 10% POPS and 15% cholesterol. The latter two contained 10% SM1, the final data
are for SUVs containing 5% GM1. The remainder of the lipid is made up of POPC. These figures
were calculated using a simple one-site ligand binding algorithm. Errors given represent standard
error from the mean, also calculated within Prism.
KDapp / µM
CD222 CD208
% POPS Y39W E46K:Y39W Y39W E46K:Y39W
0 — — — —
10 386 ± 75 110 ± 25 819 ± 489 84 ± 35
25 186 ± 41 164 ± 22 222 ± 101 122 ± 35
50 37 ± 10.8 20 ± 5 27 ± 18 17 ± 5
It should be noted that the values presented in Table 5.1 have been taken from one
data set only, but despite this limitation, the calculated KDapp are broadly similar to
those presented from the fluorescence blue shift data. Values calculated at 208 nm as
less accurate than those at 222 nm due to smaller di↵erences between the spectra, and
a greater e↵ect of noise at this wavelength. In the 50% POPS case the values are very
close to those calculated in Chapter 4; in the 10% case the two 222 nm measurements are
widely dispersed, but the mean is approximately 248 µM 1, again close to the blue shift
data. For 25% POPS, the CD data show a slightly higher dissociation constant, but still
comparable to that calculated in Chapter 4. It may be the case that the protein folding
event occurs at a lower concentration of POPS than the tryptophan membrane insertion
event, and may require higher proportions of POPS to achieve similar a nity. More data
would be required to make this case. For the data presented here, the similarities suggest
that tryptophan membrane insertion and random coil to ↵-helix protein folding take place
at roughly similar concentrations, and therefore may be considered valid representations
of the same binding process.
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5.3.2 Addition of di↵erent lipids had little e↵ect on CD
As in Chapter 4, once the POPC/POPS samples had been studied by CD, cholesterol was
added to the lipid mixture and the experiment repeated. These data are shown in Figure
5.6. When compared to Figures 5.2 and 5.4, it was clear that cholesterol had not altered
the trend – the same number of spectra appear to show random coil signal, and the same
show ↵-helix.
200 220 240 260
-20000
-10000
0
Wavelength / nm
[θ
] /
 d
eg
 c
m
2  d
m
ol
-1
CD spectra, Y39W, PC/PS/cholesterol SUVs
protein only
1:1
1:5
1:7.5
1:10
1:25
1:50
1:75
1:100
1:250
1:500
1:750
1:1000
200 220 240 260
-25000
-20000
-15000
-10000
-5000
0
5000
Wavelength / nm
[θ
] /
 d
eg
 c
m
2  d
m
ol
-1
CD spectra, E46K:Y39W, PC/PS/cholesterol SUVs
protein only
1:1
1:5
1:7.5
1:10
1:25
1:50
1:75
1:100
1:250
1:500
1:750
1:1000
Figure 5.6: CD spectra gathered for (top) Y39W, and (bottom) E46K:Y39W ↵-synucleins,
mixed with POPC/POPS/cholesterol vesicles. Vesicle composition is 15% cholesterol, 10% POPS,
75% POPC. Cuvette path length was 1mm, and protein concentration was 10µM.
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SM1 was also added to the lipid mixture. These spectra are shown in Figure 5.7, and
again there were no di↵erences to the data above. Neither lipid altered the ability of the
protein to interact with the membrane.
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Figure 5.7: CD spectra gathered for top) Y39W, and (bottom) E46K:Y39W ↵-synucleins, mixed
with phospholipid vesicles. Vesicle composition is: 10% SM1, 15% cholesterol, 10% POPS, 65%
POPC. Cuvette path length was 1mm, and protein concentration was 10µM.
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Finally, GM1 was added to the mixture. This ganglioside is known to interact with
amyloid proteins, and this experiment was intended as a means to spot a potentially critical
di↵erence in the interaction of WT ↵-synuclein, and disease-linked E46K ↵-synuclein.
Once again, however, the data did not show any noticeable e↵ect from adding GM1.
These spectra are shown in Figure 5.8.
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Figure 5.8: CD spectra gathered for (top) Y39W, and (bottom) E46K:Y39W ↵-synucleins,
mixed with phospholipid vesicles. Vesicle composition is: 5% GM1, 10% SM1, 15% cholesterol,
10% POPS, 60% POPC. Cuvette path length was 1mm, and protein concentration was 10µM.
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Figures 5.6, 5.7, and 5.8 taken together confirmed that there is little e↵ect on the binding of
Y39W or E46K:Y39W ↵-synuclein when cholesterol, SM1, or GM1 are added. Therefore,
in this system, the protein is able to interact with vesicles containing POPS, but this is
the only lipid facilitating the interaction. Interaction with POPS fits well with studies
in the literature, describing the tendency of ↵-synuclein to bind to charged vesicles,
though the work presented here goes into greater detail than the one-component vesicles
or two-component vesicles considered before (Davidson et al., 1998; Eliezer et al., 2001;
Chandra et al., 2003; van Rooijen et al., 2008; Haque et al., 2010; Reynolds et al., 2011;
Varkey et al., 2013). This interaction has been shown in greater detail than before,
demonstrating a concentration dependence with POPS at many di↵erent proportions in
the lipid mixture.
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However, a discrepancy arose from the observed lack of interaction between the protein and
GM1. As discussed in Section 4.3.3, it would be expected that ↵-synuclein would interact
with GM1 specifically (Fantini & Yahi, 2011), but in the spectra presented so far there
was no evidence of this interaction. Preliminary data was gathered using E46K:Y39W
↵-synuclein and vesicles comprising 50% GM1 and 50% POPC, prepared and mixed as
described above. These spectra are shown in Figure 5.9.
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Figure 5.9: CD spectra gathered for E46K:Y39W ↵-synuclein, mixed with phospholipid vesicles.
Vesicle composition is: 5% GM1, 95% POPC. Cuvette path length was 1mm, and protein
concentration was 10µM.
Figure 5.9 resembles the POPC-only data shown in Figure 5.2, in that there is almost no
structural change. At very high ratios of protein:lipid, around 1:500 moles, the random
coil structure is slightly diminished, and ↵-helix bands have begun to develop, but this
e↵ect is not strong, and would require further study to resolve. This result resembles that
shown in Figure 4.9, although the CD spectra show a small structural change, whereas
the fluorescence data show nothing. This could indicate that the protein begins to fold in
the presence of very high lipid levels regardless of whether the region around residue 39
has interacted with the lipid at all.
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5.3.3 Circular dichroism measurements of melittin-lipid systems
Extruded vesicles of several types were mixed with melittin, and the CD spectrummeasured
in the LD cell. The CD spectrum of melittin without lipid present was also measured.
The data are shown in Figure 5.10. These spectra show the unfolded nature of melittin
in the absence of lipid, with a band only at 200 nm. When lipid was present at a ratio of
1:100 moles (protein:lipid), ↵-helix bands developed in all cases. The 195 nm band, not
visible in ↵-synuclein spectra above, is present in all except the highly-scattering BTLE
sample. Bands at 208 and 222 nm are clear in all cases, with similar magnitudes (slightly
lower for soybean PC).
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Figure 5.10: CD spectra gathered for melittin mixed with lipid vesicles. Black line represents
melittin without lipid. In other cases, melittin was mixed with lipid vesicles at molar ratio of
1 mole protein:100 moles lipid. Path length was 500µm in total, and protein concentration was
0.1mg/mL.
Some discrepancies at higher wavelengths may be observed, for example around 270 nm.
These are attributed to some slight aberration of the LD capillary – a scratch or some
birefringence e↵ect altering the baseline (Norde´n et al., 2010). In general, however, this
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experiment gave very promising results indicating the suitability of the LD cell for CD
measurements. The CD spectra measured here are representative of those reported in the
literature (Damianoglou et al., 2010).
5.3.4 Amyloid oligomers studied by circular dichroism
The technique in Section 5.3.3 of measuring CD in apparatus designed for LD was applied
to ↵-synuclein. Spectra gathered for the monomeric Y39W protein in the absence of lipid
are shown in Figure 5.11.
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Figure 5.11: CD spectra gathered for ↵-synuclein monomer in absence of lipid. Two replicates
shown. Path length was 500µm in total, and protein concentration was 0.1mg/mL.
The data shown in Figure 5.11 demonstrate that although lower signal:noise is achieved
than in either the melittin case or the previous ↵-synuclein case described above, the key
random coil signal at 200 nm is observable in these conditions. At wavelengths lower than
around 195 nm these spectra are not useful: the signal is lost in some kind of scattering
or other aberration.
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Oligomeric ↵-synuclein was also measured by this method, and generated CD spectra
shown in Figure 5.12.
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Figure 5.12: CD spectra gathered for ↵-synuclein oligomer in absence of lipid. Two replicates
shown. Path length was 500µm in total, and protein concentration was 0.1mg/mL.
Here we observed characteristic  -sheet CD spectra, with a positive band at 195 nm and
a smaller, negative band at 219 nm. This is good evidence that the oligomer production
and purification method refined in the Pinheiro laboratory is e↵ective, as the signal is
not dwarfed by random coil signals. The data also conform to those sections of the
literature that describe amyloid oligomers as having  -sheet structure, though data has
also supported the existence of ↵-helical oligomers (Apetri et al., 2006; Rochet et al., 2000;
Sto¨ckl et al., 2012b). The signal is not high enough to overcome all the noise present for
this variation of the CD technique, but for initial estimation of secondary structure this
may be su cient in many cases. The red trace does display two unusual abnormalities:
one small band at around 340 nm, and a non-flat baseline above 400 nm. These both may
be due to birefringence or imperfections in the LD capillary. The capillaries have not been
optimised for CD, which may represent the next crucial step to developing this experiment
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further.
Figure 5.13 shows the CD spectra collected for monomeric ↵-synuclein in the presence of
the two di↵erent lipid mixtures of most interest: POPC/POPS/cholesterol, and BTLE. As
expected from the earlier monomer-lipid interaction experiments, the random coil signal
of Figure 5.11 is replaced by ↵-helix to some extent. The conversion is not complete,
as the molar ratios involved are smaller than those required for complete conversion, as
demonstrated in Section 5.3.1, but bands are visible at approximetely 208 and 222 nm.
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Figure 5.13: CD spectra gathered for ↵-synuclein monomer in presence of lipids. Black dashed
trace for the POPC/POPS/cholesterol case, blue dashed line for BTLE. Path length was 500µm
in total, and protein concentration was 0.1mg/mL.
Oligomeric ↵-synuclein was mixed in the same ratio with the same kinds of lipids, and
again CD spectra were measured. These are shown in Figure 5.14. According to these
data, the secondary structure of the oligomers is not a↵ected by the lipid environment.
The same shape and magnitude of bands is observed in this Figure as in Figure 5.12
above.
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Figure 5.14: CD spectra gathered for ↵-synuclein oligomer in presence of lipids. Black dashed
trace for the POPC/POPS/cholesterol case, blue dashed line for BTLE. Path length was 500µm
in total, and protein concentration was 0.1mg/mL.
5.4 Conclusions
In this chapter, three series of experiments have been conducted. First, CD was measured
for ↵-synuclein monomers mixed with lipid vesicles. These data demonstrate the propensity
of the protein to fold to ↵-helix when it encountered lipid. Significantly, it was possible to
determine the a nity of the protein for the lipid vesicles used by monitoring its CD signal
at the characteristic ↵-helix bands. The secondary structure of the protein changed in
a lipid ratio-dependent manner, with more ↵-helix developing as more lipid was present.
Greater proportions of POPS in the vesicle composition give much smaller dissociation
constants, i.e. the proportion of protein folded to ↵-helix is much greater, for a much
lower ratio of lipid:protein.
Binding coe cients generated in this way corroborate those generated from the fluorescence
blue shift data discussed earlier, and therefore demonstrate that the insertion of the W39
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residue into the membrane happens at the same protein:lipid ratio as the folding of the
protein. In other words, the chance that the two traits are involved in the binding process is
high, rather than insertion leading the way and folding following later, for example.
The second experiment series, to use a model protein to assess the quality of CD generated
in an LD instrument gave some significant results. Melittin appears to interact strongly
with all types of membrane used in this work. It ready adopts its ↵-helix configuration on
exposure to vesicles with mixed charges, mixed acyl chains, and diverse head groups. The
spectra gathered agree with those previously reported in the literature. More pertinently,
the quality of the spectra, while not perfect, is clear and usable. The LD cell is therefore
a suitable sample holder for CD. There may be technical aspects that can be improved
over time, reducing imperfections in capillaries for example, that will improve this use of
the apparatus further.
It is possible to draw several conclusions from the final experimental series. First, the LD
cell can be a useful tool for measuring CD. Second, ↵-synuclein monomers are dynamic
in structure, and change easily in response to their environment. This might represent
pathways to formation of oligomers, fibrils, tetramers, or some other structure, but evidence
of this was not observed here. Additionally, oligomers are stable when exposed to membranes
of varying charge and complexity, at least in the short term. CD does not indicate
any change of structure, and therefore does not indicate the nature of any interaction
between oligomer and membrane, i.e. whether the oligomers insert into the membrane.
Other techniques must be employed to make conclusions about these specific questions.
These experiments do not answer the question of how the oligomers could kill cells, but
it is reasonable to conclude that the annular structure of these oligomers would not be
immediately altered by interaction with lipids.
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Linear dichroism spectroscopy
studies of protein-lipid
interaction
6.1 Introduction
Using circular dichroism data from Chapter 5, it has been possible to test the use of the
LD cell as a chamber in which to observe secondary structural changes of melittin and
↵-synuclein as they interact with lipids. This change in secondary structure can give
clues to the strength the protein-lipid interaction. Linear dichroism gives similar clues
to binding strength in a di↵erent way: the lipids are aligned in the shear flow, and the
proteins align only if they interact with the lipids. LD, importantly, also gives clues to
the mode of protein-lipid interaction, where the sign of the LD signal indicates whether
the protein has inserted across the membrane. The quality of CD data obtainable in the
LD cell was demonstrated in Chapter 5. This success gave confidence that it was possible
to prepare a single sample, for a single instrument, and make both measurements in the
same experimental session, without even the need to change cuvette.
In this chapter, results are presented from LD experiments on the same protein-lipid
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systems as in Chapter 5: the model protein melittin, monomeric ↵-synuclein, and oligomeric
↵-synuclein. The first set of results presented demonstrate the di culties encountered in
both lipid system experiments and LD experiments. Di↵erent lipid mixtures respond to
the Couette flow in unpredictable ways, and these e↵ects are discussed. Once near-optimal
conditions were determined, the proteins were used.
Melittin has been studied by LD previously, so it was of interest whether technique and
instrument development has altered the results obtained since then (Damianoglou et al.,
2010). Once these data were in place, it was necessary to compare the LD spectra of
monomeric ↵-synuclein, to determine if its binding mode is the same as, or distinct from,
that of melittin. And finally the question of oligomer lipid-binding was addressed, to gather
data on whether these oligomers insert across the membrane, or contact in a di↵erent
way.
6.2 Materials and methods
The linear dichroism spectrum of DPH was measured after drying onto stretched polyethylene
film, in order to assess its potential as an LD probe, following modifications made to the
established stretched film approach to LD of Razmkhah et al. (Norde´n et al., 2010;
Razmkhah et al., 2014). LD was measured of stretched polyethylene film as a baseline,
then a 50mg/mL solution of DPH in chloroform was deposited onto the film surface and
allowed to dry. 8 spectra were accumulated and averaged. Couette flow LD was carried
out for vesicles with DPH incorporated into the lipid mixture at 1% w/w.
Linear dichroism spectra were measured for melittin mixed with di↵erent types of lipid
vesicle. The two sample components were mixed to a molar ratio of 1:100 (protein:lipid),
with protein at 0.1mg/mL (approximately 35µM). ↵-synuclein was mixed to a molar ratio
of 1:100 (protein:lipid), with protein at 0.1mg/mL (approximately 10µM). Monomeric
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and oligomeric forms of ↵-synuclein were used; the oligomeric form was prepared as
described in Section 2.2.6. Lipid vesicles used contained 1% w/w diphenylhexatriene
(DPH), and four di↵erent mixtures of lipids: brain total lipid extract, soybean PC,
POPC/POPS/cholesterol (molar ratio 75:10:15), and DMPC/POPS/cholesterol (molar
ratio 75:10:15). Lipids were prepared by the extrusion method described in Section 2.2.4,
and mixed with protein shortly before use. In preliminary work, the lipid vesicles were
prepared by sonication until the suspension was clear, as with the CD data gathered in
Section 5.3.1.
Couette flow LD data were gathered in Jasco J-1500 and J-815 spectropolarimeters, and
all data were collected for 80–100µL of sample in a 0.5mm path length capillary, in the LD
cell. Rotation speed was 3000 rpm, with baselines measured at 0 rpm. Measurement speed
was 200 nm/min, integration time was 0.5 seconds, and each spectrum was the average of
8 measurements. Spectra were gathered from 180 nm to 500 nm.
The orientation parameter S was calculated by solving Equation 3.6, obtaining the degree
of orientation of DPH. This calculation was carried out in MATLAB by correcting for the
scattering e↵ect of the lipid sample, then extracting the region of the spectrum where DPH
gave LD signal. S of this region was then calculated. This process is shown in Appendix
C.
6.3 Results and Discussion
6.3.1 DPH acts as a probe for orientation of vesicles
The LD spectrum of DPH was measured on PE film in order to confirm it was capable
of generating a signal in this technique. This spectrum is shown in Figure 6.1. The figure
revealed several important details, validating DPH as a useful LD probe: first, peaks
are well defined at around 200, 340, 355, and 380 nm. While the 200 nm band might
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be masked by any protein signal in an experiment, the other peaks are well clear of the
protein region, and should allow interpretation of vesicle orientation.
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Figure 6.1: LD spectrum of DPH deposited on polyethylene film.
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The LD spectra of vesicles containing DPH were measured at various concentrations in
order to demonstrate the e↵ectiveness of DPH as a probe for LD. The orientation method
was Couette flow. Representative spectra are shown in Figures 6.2 and 6.3.
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Figure 6.2: LD spectrum of DPH in lipid vesicles at approximately 50mg/mL in aqueous bu↵er.
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Figure 6.3: LD spectrum of DPH in lipid vesicles at approximately 25mg/mL in aqueous bu↵er.
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It was apparent from Figures 6.2 and 6.3 that DPH did not orient to the same extent in
all cases, and that clear trends, or reproducibility, have not been achieved. However, the
bands associated with DPH from Figure 6.1 are present to some extent in all case, and in
some cases are extremely strong. Spectra gathered with BTLE and POPC/POPS/cholesterol,
for example, are dominated by the DPH bands. In other cases, soybean PC for example,
the bands are visible but not strong, and could be overwhelmed by introductions of other
compounds. The bands for DPH have negative sign, indicating that the DPH orients as
if it were another lipid in the membrane, i.e. it is parallel to the normal to the lipid
surface.
The data shown in Figures 6.2 and 6.3 posed a problem, as it was necessary to determine
standardised, optimised, methods for utilising DPH as an LD probe, and results from
di↵erent lipid systems contradicted each other. The optimal bands for LD probes would
be present and clear, but minimal, so as not to be confused with other analytes. It was,
therefore, essential to reduce the strength of DPH LD bands, and also to reduce the
amount of lipid required for the sample, so as to be comparable with the experiments
presented in Chapters 4 and 5: i.e. 1mM, or around that order of magnitude.
DPH was incorporated into revised vesicle systems, and the LD measured. These samples
contained lipid at around 5mg/mL. Figures 6.4, 6.5, 6.6 and 6.7 show LD spectra gathered
for the lipid systems with DPH present. Figure 6.4 includes a spectrum without DPH to
verify that DPH does not influence the position of the lipid band observed.
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Figure 6.4: LD spectra of vesicles comprising POPC, POPS, cholesterol. Solid lines represent
data gathered for vesicles also containing DPH, dotted line for vesicles without. Lipids at
approximately 5mg/mL. Path length of capillary was 500µm.
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Figure 6.5: LD spectra of vesicles comprising DMPC, POPS, cholesterol and DPH. Lipids at
approximately 5mg/mL. Path length of capillary was 500µm.
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Figure 6.6: LD spectra of vesicles comprising soybean PC and DPH. Lipids at approximately
5mg/mL. Path length of capillary was 500µm.
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Figure 6.7: LD spectra of vesicles comprising brain total lipid extract and DPH. Lipids at
approximately 5mg/mL. Path length of capillary was 500µm.
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Some of the spectra presented in Figures 6.4, 6.5, 6.6 and 6.7 show that DPH gives still
gives discernible bands under these revised conditions. The proportion of DPH used was
optimised such that minimal bands would be observed in the POPC/POPS/cholesterol
sample, thereby reducing any potential impact on a signal from protein. However, it is clear
that the soybean PC vesicles do not display DPH LD signal at this concentration. DPH
may not be able to incorporate into the soybean lipids, or may have its LD signal quenched
by other vesicle components. The work presented in this thesis does not answer why this
is the case. Extensive work may be required to determine why soybean PC prevents DPH
giving strong LD. Unpublished data from the Rodger laboratory does appear to show that
if the concentration of DPH is very high (around 10% w/w), or if the lipid concentration is
very high (over 50mg/mL) it will generate an LD signal, however, this was not compatible
with the experimental aims in this case.
Another interesting result from this set of data is the strikingly di↵erent shape of the
spectrum for BTLE (Figure 6.7). While the other three systems have strongly positive
signals around 200 nm, BTLE has a very sharp negative band here. This is not easily
explained by usual factors such as scattering of light by vesicles, however there is no
evidence of an absorption band at this wavelength for BTLE. Some combination of factors,
including some scattering, may be responsible for this LD band. It is believed that the
BTLE is such a complex extract the some components of the lipid mixture are able
to give very strong negative LD signal when oriented in Couette flow, with their head
groups oriented perpendicular to the direction of the flow. There must be some other
chromophore, as yes unidentified.
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The orientation parameter S was calculated for the DPH bands observed in these lipid/DPH
LD spectra. The spectra were first corrected for sloping between 500 and 400 nm, so that
the region around the DPH bands was as uniform as possible. Table 6.1 shows the values
for S calculated here. An example of the method used for this calculation is given in
Appendix C.
Table 6.1: Values for S calculated from DPH LD signal in lipid/DPH LD spectra (1 significant
figure). An implementation of the method used for this calculation is given in Appendix C.
Lipid components S
POPC/POPS/cholesterol 0.01
DMPC/POPS/cholesterol 0.001
Soybean PC 0.0003
BTLE 0.01
It may be noted that these values are lower than those reported in Chapter 3. This
may indicate that the model should be reformulated, or that more data is needed before
calculating S.
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6.3.2 Lipid selection influences linear dichroism spectra
The LD spectrum of melittin was measured in the presence of di↵erent lipid vesicles. The
lipids selected were the same as those used for melittin CD in Chapter 5, and melittin
had adopted an ↵-helical structure when interacting with each lipid preparation.The LD
spectrum of melittin in lipid has a shape characterised previously in the Rodger laboratory
(Damianoglou et al., 2010). The data in Figure 6.8 demonstrate that despite instrumental
change, a similar spectrum is still observed. There is a strong band around 200 nm, and
a weaker band, a shoulder, around 250 nm. Unfortunately there is interference in this
band from some instrument-induced artefact around 270 nm, but the overall shape of
the spectrum remains consistent. Importantly, the DPH bands are still clearly visible,
confirming that the lipid vesicles themselves are oriented.
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Figure 6.8: LD spectrum of melittin with POPC/POPS/cholesterol/DPH vesicles (solid blue
traces), and POPC/POPS/cholesterol vesicles (dotted blue trace). Solid black trace is protein in
solution in the absence of lipid.
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Figure 6.9 shows the e↵ect of using DMPC in the lipid mixture rather than POPC. It
was demonstrated in Chapter 3 that despite its common use, this shorter chain lipid is
not necessarily the most appropriate. Here we observe that the LD spectra generated are
not consistent with each other, While the DPH signals are reasonably reproducible, the
baseline shifts, and there is unpredictable peak broadening in some cases. In other cases,
the band at 200 nm fails to develop at all. The conclusion here is that when DMPC is a
major component of the vesicles used, an LD experiment carried out in this way may well
fail.
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Figure 6.9: LD spectrum of melittin with DMPC/POPS/cholesterol/DPH vesicles (red traces).
Solid black trace is protein in solution in the absence of lipid.
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In the soybean PC case, Figure 6.10, the 200 nm band is not reliably reproduced. It
is present in some repeats, absent in others. The lack of clear DPH peaks discussed
above makes it impossible to say whether this is due to lipids failing to orient, or protein
failing to insert into the lipid. Again, the conclusion is that although this lipid extract is
easily obtained, cost-e↵ective, and easy to handle, it is not appropriate for this style of
experiment.
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Figure 6.10: LD spectrum of melittin with soybean PC/DPH vesicles (green traces). Solid
black trace is protein in solution in the absence of lipid.
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Figure 6.11 shows that the melittin plus BTLE LD spectra are consistent and clear. We
observe the DPH bands, as well as the characteristic negative BTLE band. It is also
striking that the positive band at 200 nm is present in this case, whereas it was absent in
the lipid/DPH spectra shown earlier. BTLE is a lipid extract of interest because of the
neurodegeneration aspect to this work. The fact that promising LD spectra are generated
in this context makes it a very promising candidate for further work.
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Figure 6.11: LD spectrum of melittin with BTLE/DPH vesicles (pink traces). Solid black trace
is protein in solution in the absence of lipid.
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6.3.3 Linear dichroism measurements of ↵-synuclein with lipid vesicles
Monomeric ↵-synuclein was mixed with lipid vesicles, and its LD spectrum measured.
Initially, the lipid preparation was by the simpler method of sonication rather than
extrusion, i.e. the method used in Sections 4.3.1 and 5.3.1. This produced the data
shown in Figure 6.12. These data show no LD bands, and no e↵ect of lipid concentration
on the spectra. It was deduced that this sample preparation is not appropriate for these
experiments.
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Figure 6.12: LD spectra of ↵-synuclein with POPC/POPS/cholesterol vesicles at di↵erent
molar ratios of protein:lipid.
The e↵ect of sonication on a lipid suspension is to generate unilamellar vesicles, as required
in these experiments, however this process will lead to other consequences. The length of
time sonication is performed will a↵ect the average particle size, and will usually result in a
sample with a large dispersity of particle size. Such a sample would be expected to scatter
light unpredictably, thereby reducing data quality. Extrusion, on the other hand, usually
results in a narrow distribution of particle sizes. Due to the poor quality of the data shown
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in Figure 6.12, the lipid preparation method was altered to use the same method as for the
results gathered in Sections 6.3.1 and 6.3.2. The vesicles chosen were the same as those
selected as for the LD cell experiment in Chapter 5: POPC/POPS/cholesterol, and brain
total lipid extract. Figures 6.13 and 6.14 show the LD spectra gathered for ↵-synuclein
mixed with POPC/POPS/ cholesterol/DPH vesicles. A band is clearly visible at 200 nm,
as are the bands for DPH discussed above. An artefact is present in some spectra at
270 nm due to an instrumental issue.
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Figure 6.13: LD spectra of ↵-synuclein with POPC/POPS/cholesterol/DPH vesicles. Green
traces are for monomeric protein samples with lipid, blue for lipid only. Solid line for Y39W,
dashed line for E46K:Y39W. An aberration is observed at around 270 nm due to an instrumental
fault, however the rest of the curve is believed to be sound.
134
CHAPTER 6. LINEAR DICHROISM
200 250 300 350 400 450 500
-0
.0
01
0.
00
0
0.
00
1
0.
00
2
0.
00
3
0.
00
4
LD spectra, α-synuclein oligomer with lipid
Wavelength / nm
LD
Figure 6.14: LD spectra of ↵-synuclein with POPC/POPS/cholesterol/DPH vesicles. Green
traces are for oligomeric protein samples with lipid, blue for lipid only. Solid line for Y39W, dashed
line for E46K:Y39W. An aberration is observed at around 270 nm due to an instrumental fault,
however the rest of the curve is believed to be sound.
Figures 6.15 and 6.16 show LD spectra gathered for ↵-synuclein with BTLE/DPH vesicles.
Similarly to Figures 6.7 and 6.11, a negative band was present at around 210 nm. One
spectrum has a disrupted baseline but the DPH bands and protein band are as expected.
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Figure 6.15: LD spectra of ↵-synuclein with BTLE/DPH vesicles. Black traces are for
monomeric protein samples with lipid, pink for lipid only. Solid line for Y39W, dashed line for
E46K:Y39W.
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Figure 6.16: LD spectra of ↵-synuclein with BTLE/DPH vesicles. Black traces are for
monomeric protein samples with lipid, pink for lipid only. Solid line for Y39W, dashed line for
E46K:Y39W. An aberrant baseline is observed in the Y39W spectrum, however the bands at the
lowest wavelengths are believed to be sound.
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While Figures 6.13, 6.14, 6.15 and 6.16 do show bands of LD signal, it is not clear by eye
whether this is due to the protein or the lipid present, and if there is a di↵erence between
the monomer and oligomer cases, or between the Y39W and E46K:Y39W cases. Hence
di↵erence spectra were created. These were generated by subtracting the spectra for lipid
with DPH from the spectra for protein with lipid and DPH. This process has the e↵ect of
increasing noise and enhancing aberrations in the spectra, but does present the LD signal
for the oriented protein alone. These di↵erence spectra are shown in Figures 6.17, 6.18,
6.19 and 6.20.
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Figure 6.17: LD di↵erence spectra for ↵-synuclein monomer mixed with POPC/POPS/
cholesterol/DPH vesicles, where lipid spectra have been subtracted from protein + lipid spectra.
Aberrations at around 270 nm have been exacerbated by this process.
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Figure 6.18: LD di↵erence spectra for ↵-synuclein oligomer mixed with POPC/POPS/
cholesterol/DPH vesicles, where lipid spectra have been subtracted from protein + lipid spectra.
Aberrations at around 270 nm have been exacerbated by this process.
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Figure 6.19: LD di↵erence spectra for ↵-synuclein monomer mixed with BTLE/DPH vesicles,
where lipid spectra have been subtracted from protein + lipid spectra. Aberrations at around
270 nm have been exacerbated by this process.
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Figure 6.20: LD di↵erence spectra for ↵-synuclein oligomer mixed with BTLE/DPH vesicles,
where lipid spectra have been subtracted from protein + lipid spectra. Aberrations have been
exacerbated by this process.
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There is one important problem with combining two LD spectra in this manner: since
spectra are combined linearly, the range of error is doubled, reducing the significance of
conclusions drawn from the data. However, the di↵erence spectra provide good data here.
From the green traces in Figure 6.17 and the black traces in Figure 6.19, we observe
that the monomeric ↵-synuclein has a positive band, similar to that for melittin, around
200 nm. This indicates that the protein is oriented in the same direction as the Couette
flow – along the surface of the long side of compressed vesicles. This confirms the NMR
data cited above in an entirely di↵erent experimental setup.
In POPC/POPS/cholesterol vesicles (Figure 6.18), the oligomer does not have this 200 nm
band at anything near the same magnitude. It could be said that something of a band
remains here, but not reproducibly so. In short, the oligomer has not oriented parallel to, or
perpendicular to, the Couette flow, and therefore there is no data in this Figure to suggest
the oligomer has interacted with the lipids. In BTLE (Figure 6.20), the oligomer samples
give a negative band at 205 nm, the same position as the negative band for BTLE alone.
In this case, therefore, the protein has generated even greater negative signal, implying
that the protein oligomer has inserted into the membrane, as discussed in Section 1.8.3
and Figure 1.19. The oligomer is oriented perpendicular to the Couette flow, suggesting
that in this case the oligomer has inserted across the membrane. This potentially validates
the hypothesis that oligomers act as pores through the membrane, and is the first time
LD has been used to show this result.
However, the signals and bands obtained are weak, and therefore do not represent a
strong argument at this point. It is recommended that further study be carried out into
other improvements to technique or sample preparation, in order to obtain higher quality
data.
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6.4 Conclusions
The results presented in this chapter give promising scope for the use of DPH as an LD
probe. This easily-handled compound is incorporated into some types of vesicles readily,
and gives good, reproducible LD signal. In some cases, however, insertion is not observed
at low concentrations, so some screening before proceeding with a lipid choice is necessary.
This is unfortunately true of soybean PC, which is a good lipid system in many other
experimental types.
Instrumental technology has evolved over the last decade or so, and at times LD data
has not been reproducible between generations. The data on LD of melittin shows that
the latest instruments (namely the Jasco J-1500) reproduce features of melittin spectra
generated in the past. This allows us to proceed with confidence, and use the technique
to probe more deeply into protein-lipid interactions.
This chapter also shows that LD has the potential to be a powerful tool in understanding
amyloid oligomers. These experiments have shown that it is possible to detect whether
or not an amyloid oligomer preparation with interact with a lipid vesicle preparation,
opening routes to straightforward screening assays - several oligomer preparations could
be presented with several lipid preparations and then pairs that gave LD signal taken
forward for more detailed study. There is also the intriguing prospect of measuring
the formation of oligomers. The positive LD signal observed for monomeric ↵-synuclein
would be reduced and replaced with the negative oligomeric signal. Conditions obviously
need to be improved to observe this process, and potentially need incubation over long
periods of time. No indication of oligomerisation was observed in the experiments reported
here.
The quality of LD di↵erence spectra was low in the experiments presented here. Some
further refinement of the technique and sample preparation will be necessary to fully
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understand the LD obtained from ↵-synuclein–lipid experiments.
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Discussion
There were two major interlinking themes to the work described above: the ability of two
constructs of ↵-synuclein to interact with lipids, and the understanding and manipulation
of vesicles in Couette flow. The link between these themes was in using linear dichroism to
study the protein-lipid interaction, generating results giving clues to the method of toxicity
of the protein: a cause of Parkinson’s Disease. The interdisciplinary approach taken to
the work has led to a collection of studies giving insights into amyloid-lipid interaction,
lipid vesicle behaviour, and good practice for LD experimentation.
7.1 Amyloid-lipid interaction
It has been emphasised many times in this thesis that key to the function and disfunction
of ↵-synuclein is its interactions with lipids. Whether its true role is in vesicle transport
or not, its interactions with lipids are the major focus of the field (Lotharius & Brundin,
2002; Auluck et al., 2010; Pfe↵erkorn & Lee, 2010; Fantini & Yahi, 2011). The combination
of intrinsic tryptophan fluorescence and circular dichroism presented in this work, has
allowed investigation into a protein-lipid interaction in more detail than before – that of
↵-synuclein and POPS. Two constructs of the protein were used, one with the Parkinson’s
Disease mutation E46K, and both with the mutation Y39W. The CD and fluorescence
data gathered demonstrated two aspects of the lipid interaction very clearly – the change
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in secondary structure of the protein, and the change in environment of the aromatic
tryptophan.
As the environment of the tryptophan residue changed, as it became buried in the lipid
membrane, a shift in  max was observed. This shift was recorded, and plotted against
the ratio of lipid:protein in the samples, thereby giving binding curves. Binding curves
were also obtained by plotting the same lipid:protein molar ratio against the CD signal at
208 nm and 222 nm (the positions of ↵-helix bands in CD). Apparent dissociation constants
were obtained from these measurements that indicated both processes were occurring at
roughly similar lipid:protein ratios. While the data may be improved by further work, this
result implies that when the protein encounters the lipid vesicle and interacts, it adopts
its folded structure. There would likely not be a population of unfolded protein anchored
by the tryptophan to the membrane, though there could be some bound, aggregated
protein.
It was believed that the interaction between POPS and ↵-synuclein was non-specific, and
due to the charge on the lipid head group. Several other lipids were used in combination,
in order to determine if binding by di↵erent methods was possible. Cholesterol, SM1, and
GM1 did not influence binding. This was of some concern, as GM1 has been shown to
bind ↵-synuclein in other studies. It is believed that the Y39W mutation removed this
binding ability, despite the similarity in size and structure of tyrosine and tryptophan,
shown in Figure 7.1.
From the work presented here, and that of Fantini and Yahi, we may conclude that Y39 is
crucial for interaction with GM1, and not simply because of its hydrophobicity (Fantini &
Yahi, 2011). However, in their simulations, it was shown that Y39F still retains its ability
to bind the ganglioside GM3, and only a substitution for a small group, like the methyl
obtained by the Y39A mutation, will remove the binding. In their study, the flanking
lysine residues, K34 and K45, play just as important a role as Y39 in the interaction.
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Figure 7.1: (left) Tyrosine and (right) Tryptophan.
The mutated proteins in this thesis still retain these lysine residues, so why the binding
ability is lost by Y39W remains unclear. This warrants deeper study, as GM1 or other
gangliosides, enriched in brain lipids, could be key to the PD-causing ability of ↵-synuclein,
as they may be for prion protein diseases (Sanghera et al., 2011).
The lipid binding experiments represent a more thorough study of the ability of these
two constructs of ↵-synuclein to interact with carefully selected model membranes than
has gone before. This data should be complemented with data for wild type protein in
order to more fully understand the implications for Parkinson’s Disease mechanisms, but
it has value as a standalone study in its own right. The possible loss of ability to interact
with GM1 may explain why there are no very dramatic di↵erences between the constructs
examined here, or perhaps we should not expect such di↵erences as PD is clearly a very
subtle disease that takes many decades to become apparent. In any case, these data are
relevant and useful for any researcher aiming to carry out similar studies considering using
Y39W constructs. They would have to prepare to use WT much more extensively.
7.2 Lipid vesicle behaviour
A combination of classic dye-leakage assay and Couette flow revealed that vesicles formed
from some lipids can withstand the forces involved in LD much better than others. This
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was an important result for lipid biophysics, as lipid selection may heavily influence the
quality of data obtained if any shear flow was required by an experiment. Certain lipids,
such as the DMPC commonly used in NMR experiments, did not seem to have any integrity
once formed into vesicles. It was shown, however, that combining DMPC with the longer
POPS, and cholesterol, enabled it to be stable in LD, although it still failed to generate
completely reproducible data. Other lipids were much more reliable, and would make
vesicles capable of enduring LD, POPC for example.
The calcein leakage in flow assay also gave rise to a new experimental design. While
not employed here, it was determined that the relationship between calcein concentration
and the position of its  max was robust enough to use as a calibration curve. A suitable
experimental design would be able to determine the concentration of calcein from  max,
rather than in the relative terms as presented in this thesis. The fact that calcein
fluorescence exhibits this property, of concentration-dependent shift may be useful to
several lipid-using fields. Lipid preparation methods are varied in protocol and in results,
and it may be di cult to accurately determine the concentration of lipid or other sample
components. Often, the leakage of the vesicle is the important result, for example when
studying pore-forming proteins from infectious agents, hence the use of calcein. This
result allows concentration of calcein to be accurately measured, therefore reducing some
uncertainty in such an experiment.
Theoretical work was carried out to understand further vesicles in flow. It was possible
to obtain a range of possible length and radius parameters, and then implement the
method of McLachlan et al. to calculate the orientation parameter S of vesicles with
those dimensions. It was determined that a vesicle would be stretched to be around three
times as long as they were wide in the flow, if it was to generate the observed values for
S. This validated experimental data from other work (Mader et al., 2006).
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7.3 Good practice in linear dichroism
As demonstrated by Figure 6.12, samples that would be expected to give CD signals and
fluorescence signals do not necessarily give LD signals. This may be due to chromophores
in the samples not orienting, or may be due to poor sample preparation. Lipids are
notoriously light-scattering in spectroscopy, and the data shown in Figure 6.12 demonstrate
that overcoming this characteristic in one technique does not solve the issue in another.
The sonication method of vesicle preparation used in Chapter 4, was not suitable for
generating good LD data. Once the extrusion method was adopted, as used in Chapter 3,
good LD spectra were generated, shown in Figures 6.4 and 6.7, for example. Data were
generated for lipids with and without DPH, for lipids and melittin together, and for lipids
and ↵-synuclein together. While the quality for ↵-synuclein spectra was low, this was the
first time such data has been gathered for either the monomeric or oligomeric forms of
the protein. Work that further optimised the technique could answer questions about the
toxicity of the protein: if we knew that oligomers inserted across the membrane and the
resulting pore was responsible for cell death, a drug target could be the pore itself. If the
oligomer does not cross the membrane but lies on the surface, then this interaction may
represent a target for intervening in Parkinson’s Disease.
It was apparent from the data gathered for lipid behaviour that only certain lipids can
endure the Couette flow aspect of LD experiments. Vesicles made from POPC/POPS/
cholesterol, and extruded rather than sonicated, have the most optimal characteristics of
those studied in this work. However, vesicles prepared from brain total lipid extract were
also well suited to LD. These provided a novel lipid mixture for studies of this kind, and
did give some data, but the lipids themselves require additional study. The very strong
negative LD band they generate has been shown to be characteristic of this mixture, but
has not been attributed to any specific component as yet. It would be desirable to delve
more deeply into why this characteristic spectrum is generated, before using BTLE for
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further LD of proteins.
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Conclusions and future work
8.1 Conclusions
It has been shown in this thesis that in order to achieve experimentally feasible values for
the orientation parameter S, vesicles of around 100 nm diameter should be compressed,
and stretched to around 180 nm in length. This causes their volume to decrease by 25%,
and the shape to change from sphere to capsule around three times longer than the width.
When dye-leakage assays were carried out, however, it was determined that this is not
true for di↵erent types of vesicles. Vesicles of di↵erent compositions behave di↵erently
in flow, with some compositions (e.g. pure DMPC) leaking vastly more of their contents
even without flow. Only two of the vesicle types tested here compared favourably to
the theoretical data: POPC/POPS/cholesterol, and DMPC/POPS/cholesterol. Vesicle
choice, therefore, may be considered crucial to any lipid shear flow experimental design.
By measuring the shift in tryptophan fluorescence emission, the ability of two Y39W-
containing ↵-synuclein constructs to interact with lipid vesicles was measured. In the data
presented here, only POPS was found to bind the protein, with POPC, cholesterol, GM1
and SM1 not showing any increase on the binding a nity. Indeed, the more complex the
SUVs used in this experiment, the lower the binding a nity seemed to be. It was shown
that the predicted ability of the protein to interact with GM1 is not detected here. One
explanation for this is that the Y39 residue is key for this interaction, and Y39W is not
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su ciently similar to retain binding ability. Similar binding data to those obtained from
fluorescence were obtained from circular dichroism experiments. Since the dissociation
constants observed were fairly similar in both cases, it may be concluded that the folding
of the protein to ↵-helix occurs at similar lipid:protein ratios as the insertion of W39 into
the lipid bilayer. Di↵erences between E46K and WT protein that may be apparent in a
future experiment using GM1 could have been obscured here due to the Y39W mutation,
so the main conclusion from this work is that E46K:Y39W and Y39W interact with lipids
with similar a nity.
CD data presented in this thesis also demonstrated that viable spectra may be obtained
even when using the LD cell. Small volumes of sample (50 – 100µL) generated strong
spectra even with lipids present, and despite the non-optimal shape of the LD capillary.
Spectroscopists may use this system with confidence if they wish to quickly determine the
secondary structure of protein samples before gathering LD spectra. The system is not
perfect, however, and some aberrations still exist. These were revealed in measuring the
CD spectrum of ↵-synuclein in various forms, so further optimisation would be needed to
get the most out of the technique. It has been shown here that the ↵-synuclein monomers
used in this work fold to ↵-helix from random coil as expected, and this is observable in
data gathered in the LD cell. The ↵-synuclein oligomers used here maintain their  -sheet
folding in the presence and absence of lipid, indicating their stability. Since they seem not
to be altered by the vesicles, they may form viable pores in the membrane, or they may
not to interact with the membrane at all.
DPH has been validated in this work as a good probe for LD of vesicles. It has clear bands
on the LD spectra, and appears to incorporate into most of the lipids tested here. In some
cases, such as soybean PC, it does not perform as well, however, and di↵erent probes may
be more suitable. It was shown that LD of melittin in di↵erent sorts of lipids than those
tested previously can be measured and gives data comparable to that in the literature,
with the interesting exception that vesicles of DMPC/POPS/cholesterol seem to not be
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reliable, only giving usable data on some occasions. When the LD of ↵-synuclein was
measured, it was found that the signals were di cult to interpret by eye, and di↵erence
spectra were required to remove the LD of the lipids used. These showed that in general
the protein oriented on the vesicle surface, but in one case (oligomeric ↵-synuclein with
brain total lipid extract) appears to insert across the membrane, supporting the hypothesis
that amyloid oligomers act as membrane pores. However, more data and a more reliable
quality of data would be needed to make this case strongly. The data gathered were not
of convincing quality, and only hint at underlying mechanisms.
8.2 Suggestions for future work
• LD of ↵-synuclein to be strengthened
Di↵erence spectra were required here to observe the weak signals generated by the
protein. It might be beneficial to take conditions and concentrations that are less
representative of biology to get improved LD here. Stronger signal:background would
improve the data. Some technical problems were encountered following adoption of
new instruments. Correcting these errors should improve the data gathered.
• Understanding the e↵ect of the Y39W mutation
The choice of Y39W constructs of ↵-synuclein was justified by its proximity to the
residues associated with Parkinson’s Disease, but may be flawed if Y39 is essential
for the interaction with GM1. Were it to be proved that interaction with GM1 is
critical to development of PD, it would be vital to understand both this interaction,
and why Y39W damages it. A preliminary attempt at solving this problem is shown
in Appendix A.
• Understanding the poor LD signal of DPH in soybean PC
The LD signal of DPH appears suppressed in soybean PC, especially when compared
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to its signal in the other lipid systems. Soybean PC is usually an ideal lipid mixture
to work with – a natural extract, cheap, easy to handle, and with reasonable solubility
in chloroform – so ruling it out for this sort of lipid work is not desirable. While DPH
LD signal can be achieved in soybean PC, the concentration of DPH or of lipid in
the sample must be much higher than required for the experiments presented here.
Some work solving why this should be the case might go a long way to improving
insertion of compounds into membranes generally, and may improve the quality of
LD overall.
• Understanding BTLE
While BTLE has provided interesting data in this thesis, a question remains over
what causes its characteristic negative LD band. The lipid mixture itself is poorly
characterised, but a thorough attempt at this, perhaps by FTICRmass spectrometry,
might shed some light on which components would be oriented perpendicular to
membrane normal.
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Appendix A
Ultracentrifugation assay
A.1 Introduction
In Chapters 4 and 5, it was noted that ↵-synuclein does not seem to have specific binding
a nity for GM1 in these studies – a somewhat surprising result. The ↵-synuclein constructs
used here contain the Y39W mutation, however, and Y39 has the putative crucial role in
the ability of the protein to bind to the gangliosides (Fantini & Yahi, 2011). Y39W was
selected for the experiments discussed in Chapters 4 and 5 because intrinsic tryptophan
fluorescence is a sensitive and straightforward technique. However, it was believed that
a technique that did not rely on changing the native Y39 residue, in order to deduce
if the Y39W mutation damaged the ability of the protein to bind ganglioside. The
following experiment was carried out in order to assess the ability of wild type, E46K,
and E46K:Y39W ↵-synuclein to bind vesicles containing GM1.
The Bradford assay for determining protein concentration, is long-established, and known
to biochemists as a matter of course, updated by the availability of the necessary reagent
and refined method from Bio-Rad (Hercules, CA, USA) (Bradford, 1976). This assay was
used to determine the concentration of protein in solution after incubation of the protein
with lipid, and separation using ultracentrifugation. Protein remaining after separation
is unbound, and can be compared to the amount unbound from other constructs of the
protein.
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A.2 Materials and methods
Lipid vesicles were prepared as described in Section 2.2.3. Lipids used were 50% GM1
and 50% POPC.
Bradford assay reagent was obtained from Bio-Rad (Hercules, CA, USA). Lipid and protein
were mixed and incubated for 10minutes, then ultracentrifugation was carried out for
10minutes at 100,000 g to separate lipids from unbound protein. The Bradford assay was
then carried out according to Bio-Rad instructions, using a Jenway 6300 spectrophotometer,
and concentrations recorded. The Bradford assay was calibrated by the curve shown in
Figure A.1.
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Figure A.1: Calibration curve for the Bradford protein concentration assay in the relevant
range. Each data point is the average of three replicates.
A.3 Results and discussion
Concentration of unbound protein was recorded as a percentage of the initial concentration,
for the three protein constructs. These data are shown in Figure A.2. This experiment
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was not replicated, and so this may only be treated as qualitative data.
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Figure A.2: Percentage of free protein remaining in solution after incubation with lipid vesicles
and ultracentrifugation. Lipid vesicles used were sonicated SUVs containing 50% POPC and 50%
GM1. Data is drawn from one replicate only.
As shown in Figure A.2, in most cases less protein remains in solution for samples
containing a higher ratio of lipid to protein, i.e. with more lipid present, more protein
is bound. However, this is the only clear trend in the data. Wild type shows the lowest
binding (highest unbound percentage) in the 5:1, 100:1, and 250:1 moles samples, but not
in the other two cases. E46K shows stronger binding than E46K:Y39W in two cases, but
not in the other three. From the literature, it was expected that E46K would bind most
strongly, but this is not shown in the data presented here.
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A.4 Conclusions
The data presented in this appendix do not suggest any clear conclusions. In some cases
E46K bound most strongly, in others E46K:Y39W. Wild type bound least strongly in some
cases, not in others. This experiment was not repeated. With more sensitive equipment
this technique might be a useful alternative to the CD and fluorescence work discussed
above, but in this case the data were inconclusive.
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Binding curve fitting report
B.1 Report generated by Prism during curve fitting
The following tables were generated by Prism when fitting the one site ligand binding
curves shown in Chapter 4 and Chapter 5. It includes the statistical tests employed in the
fitting process. Fitting data are shown for fluorescence experiments with POPC/POPS
lipids, with complex lipids, and for CD experiments with the POPC/POPS SUVs.
Equation: Ligand Binding, one site saturation
f = Bmax ⇤ abs(x)
Kd + abs(x)
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Appendix C
Solving for orientation
parameter
C.1 Method for calculating S
Having generated LD spectra of DPH in lipid, the parameter S (as in Equation 3.6)
was calculated, in order to quantify the LD signal observed. The code given below
demonstrates the approach taken to this calculation for one example. This was implemented
in MATLAB. The figure generated by this code is shown in Figure C.1. The LD spectrum
is partially corrected for slope caused by scattering by subtracting a straight line fitted to
the high wavelength region of the spectrum. LDr is calculated from LD and absorbance
spectra, then S calculated for the whole spectrum. The region around the DPH peaks is
extracted such that no other peak is considered, and then the highest value taken as the
value for S for DPH in that sample.
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Figure C.1: Figure generated in MATLAB showing LD spectrum of DPH in POPC/POPS/
cholesterol vesicles (blue trace) and isolated region of LDr spectrum (red trace) around DPH peaks.
The LDr trace outside of the region around the DPH peaks has been set to zero.
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f
S
th
e
re
V
p
25
=
z
e
ro
s
(
3
2
0
1
)
;
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p
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fo
r
i
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V
p
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(
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1
1
8
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)
=
p
o
p
2
5
p
e
a
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s
(
i
)
;
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n
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e
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e
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s
fi
g
u
r
e
%
p
lo
t
t
in
g
p
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t
(p
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o
p
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5
L
D
)
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